Your browser is no longer supported. Please, upgrade your browser.
Settings
WMT Walmart Inc. daily Stock Chart
WMT [NYSE]
Walmart Inc.
IndexDJIA S&P500 P/E60.60 EPS (ttm)1.65 Insider Own0.90% Shs Outstand2.86B Perf Week4.61%
Market Cap286.23B Forward P/E21.20 EPS next Y4.72 Insider Trans-68.89% Shs Float1.38B Perf Month3.78%
Income4.89B PEG14.53 EPS next Q1.33 Inst Own30.30% Short Float1.10% Perf Quarter-2.87%
Sales511.88B P/S0.56 EPS this Y-26.80% Inst Trans0.04% Short Ratio1.78 Perf Half Y10.83%
Book/sh24.62 P/B4.06 EPS next Y-2.54% ROA2.50% Target Price107.00 Perf Year-1.68%
Cash/sh3.20 P/C31.20 EPS next 5Y4.17% ROE7.00% 52W Range81.78 - 106.21 Perf YTD7.34%
Dividend2.08 P/FCF23.23 EPS past 5Y-8.50% ROI10.40% 52W High-5.86% Beta0.35
Dividend %2.08% Quick Ratio0.20 Sales past 5Y1.30% Gross Margin25.20% 52W Low22.27% ATR1.50
Employees2300000 Current Ratio0.80 Sales Q/Q1.40% Oper. Margin2.80% RSI (14)67.11 Volatility1.16% 1.57%
OptionableYes Debt/Eq0.80 EPS Q/Q-3.10% Profit Margin1.00% Rel Volume1.10 Prev Close98.52
ShortableYes LT Debt/Eq0.64 EarningsFeb 19 BMO Payout118.20% Avg Volume8.53M Price99.99
Recom2.30 SMA203.50% SMA505.88% SMA2008.41% Volume9,480,983 Change1.49%
Feb-08-19Initiated Buckingham Research Neutral
Jan-23-19Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-20-18Downgrade Daiwa Securities Outperform → Neutral
Sep-14-18Resumed Goldman Neutral $101
Aug-17-18Reiterated Telsey Advisory Group Outperform $105 → $107
Aug-17-18Downgrade Raymond James Strong Buy → Outperform
Jul-25-18Downgrade Gordon Haskett Buy → Hold
May-10-18Reiterated Telsey Advisory Group Outperform $110 → $105
Apr-19-18Upgrade Argus Hold → Buy $100
Apr-06-18Initiated Loop Capital Hold $92
Feb-26-18Initiated Credit Suisse Neutral
Feb-21-18Reiterated Telsey Advisory Group Outperform $120 → $110
Feb-21-18Reiterated Stifel Hold $104 → $99
Dec-19-17Upgrade Citigroup Neutral → Buy $106 → $117
Dec-04-17Initiated MoffettNathanson Neutral
Nov-20-17Downgrade Goldman Buy → Neutral
Nov-17-17Reiterated Telsey Advisory Group Outperform $96 → $108
Nov-17-17Reiterated RBC Capital Mkts Underperform $83 → $92
Nov-15-17Reiterated Oppenheimer Outperform $90 → $100
Oct-11-17Reiterated Telsey Advisory Group Outperform $88 → $92
Feb-19-19 05:00AM  Walmart Reports Earnings Today. Heres What to Expect. Barrons.com
01:09AM  British supermarkets battle to secure stocks as chaotic Brexit looms Reuters
01:00AM  FOCUS-British supermarkets battle to secure stocks as chaotic Brexit looms Reuters
Feb-18-19 07:24PM  Dow Stocks Microsoft, Cisco, Walmart Just Entered Buy Range; Take A Closer Look Investor's Business Daily
05:54PM  Top 5 Companies Owned by Walmart (WMT) Investopedia
04:14PM  Correction: Grab And Go Shopping story Associated Press
02:58PM  Amazon is hurting main street America': Former Toys R Us CEO Fox Business Videos
01:01PM  Walmart's 4th-Quarter Financials: A Preview GuruFocus.com
11:59AM  What to Expect When Walmart and CVS Report Earnings This Week TheStreet.com
11:18AM  Walmart Reports Earnings as It Recovers From Its Christmas Eve Low TheStreet.com
11:03AM  Today's Pickup: Smiley Sails Away From NYC; Walmart Builds An Intermodal Box Operation Benzinga
10:04AM  After long weekend, Walmart highlights a short week of earnings MarketWatch
10:03AM  Walmart earnings preview: Grocery sales expected to give the retail giant a boost MarketWatch
Feb-17-19 12:00PM  4 Earnings Reports I'll Be Watching This Week TheStreet.com
12:46AM  Economic Calendar - Top 5 Things to Watch This Week Investing.com
Feb-16-19 12:26PM  What to Expect for the Markets Next Week Investopedia
Feb-15-19 08:00PM  Under Armour Is Under Siege, but Constellation Brands, Activision Blizzard, and Walmart Are Humming Barrons.com
06:47PM  Cramer's game plan: Investors shouldn't underestimate the importance of a trade deal with China CNBC
05:40PM  Time to go shopping in retail? Big box breaks out CNBC Videos
05:36PM  What to watch in the markets: Week of February 18 Yahoo Finance Video
05:32PM  3 Things to Know About Q4 Earnings Season Zacks
05:28PM  Mattel inks Despicable Me deal, Jakks gets Warners Godzilla American City Business Journals
04:27PM  The Fed could move markets this week when it tells us what it was thinking at the January meeting CNBC
01:07PM  Apollo affiliates to buy stake in Cox Media Group TV stations CNBC
11:40AM  3 Earnings Reports to Watch Next Week InvestorPlace
11:17AM  Walmart 'holding its own' against Amazon ahead of earnings report CNBC
10:11AM  Multiple Aspects of Walmarts Q4 Results Will Affect Walmart Stock InvestorPlace
Feb-14-19 07:27PM  [$$] Earnings Season to Offer Next Test for Retail Stocks The Wall Street Journal
05:59PM  Humbug holidays: US retail sales drop 1.2 pct in December Associated Press
04:13PM  Retail ETF Investors Will Look to Upcoming Earnings to Confirm Strength ETF Trends
03:02PM  Walmart is putting trailers equipped with VR technology in its parking lots, with plans to bring it to stores CNBC
02:01PM  Why Starbucks (SBUX) Stock Looks Like a Strong Buy at New High Zacks
01:51PM  Walmart, DreamWorks make riding a dragon a (virtual) reality American City Business Journals
01:01PM  Why Walmart farms out same-day grocery deliveries to low-cost freelance drivers Reuters
12:37PM  Why Walmart farms out same-day grocery deliveries to low-cost freelance drivers Reuters
10:41AM  Walmart startup partners with DreamWorks for 'How to Train Your Dragon' virtual reality experience MarketWatch
10:40AM  The Zacks Analyst Blog Highlights: Boeing, Microsoft, Amazon, Walmart and JPMorgan Zacks
10:28AM  Toys R Us' Second Act: Does It Have a Chance? Motley Fool
10:11AM  Walmart's low-cost grocery delivery plan Reuters Videos
09:40AM  Walmarts Latest Move Could Hurt Bed Bath & Beyond Motley Fool
09:16AM  Data localisation, e-commerce not discussed at U.S.-India summit: U.S. envoy Reuters
08:00AM  Will Higher Revenues Drive Sprouts Farmers' (SFM) Q4 Earnings? Zacks
07:57AM  How Rent-A-Center (RCII) Looks Just Ahead of Q4 Earnings Zacks
07:52AM  Data localisation, e-commerce not discussed at U.S.-India summit: U.S. envoy Reuters
07:00AM  FOCUS-Why Walmart farms out same-day grocery deliveries to low-cost freelance drivers Reuters
06:45AM  Why Walmart farms out same-day grocery deliveries to low-cost freelance drivers Reuters
12:01AM  Walmart and DreamWorks Animation Invite Fans to Step Into the Hidden World of How to Train Your Dragon Through New Virtual Reality Experience Business Wire
Feb-13-19 07:54PM  Walmart in Mexico squeezes suppliers, profits jump in quarter Reuters
07:21PM  Will Walmart's Holiday Quarter Bolster Its E-Commerce Growth? Motley Fool
05:23PM  What to Expect from CVS Health's Q4 Earnings, Revenue & Comps Zacks
04:45PM  Mexico's Walmex posts 11 pct jump in Q4 net profit Reuters
04:41PM  5 Must See Earnings Charts Zacks
04:12PM  Mexico's Walmex reports fourth qtr net profit of 11.8 billion pesos Reuters
03:45PM  Product Expansion to Aid Applied Materials (AMAT) Q1 Earnings Zacks
02:43PM  Here's What to Expect from Walmart's (WMT) Q4 Earnings Results Zacks
02:43PM  Walmart Stocks Rocky 2018 Could Put It on the Right Path in 2019, Analyst Says Barrons.com
01:17PM  Jeans maker Levi Strauss files for stock market comeback Reuters
01:04PM  Jeans maker Levi Strauss files for stock market comeback Reuters
12:52PM  WSU Tech president Sheree Utash joins heavy hitters in advising Trump Administration American City Business Journals
10:49AM  Apple, Walmart, IBM CEOs join White House advisory panel Reuters
10:19AM  Apple, Walmart, IBM chief executives join White House advisory panel Reuters
08:43AM  5 Retail Stocks Likely to Steal the Show This Earnings Season Zacks
08:12AM  5 Stocks That Prove Size Does Matter in 2019 Zacks
07:55AM  What's in Store for Companhia Brasileira's (CBD) Q4 Earnings? Zacks
07:34AM  What Is A Tariff, Who Pays, And What Is The Purpose Of A Tariff? Investor's Business Daily
Feb-12-19 05:49PM  Walmart and Deliv end online grocery partnership Reuters Videos
05:45PM  Walmart (WMT) Gains But Lags Market: What You Should Know Zacks
04:40PM  Walmart to Host Fourth Quarter Earnings Conference Call on Feb. 19, 2019 Business Wire
11:16AM  7 stocks that prove bigger is better in 2019 MarketWatch
10:53AM  Friends' gluten-free cookie mixes headed for Walmart American City Business Journals
10:31AM  Walmart (WMT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
09:50AM  Whole Food price hike is good news for Walmart, says Jim Cramer CNBC Videos
08:40AM  Walmart, Deliv End Partnership in Blow to Walmart's Same-Day Delivery Option TheStreet.com
07:58AM  Will Omnichannel Play Key Role in Walmart (WMT) Q4 Earnings? Zacks
07:00AM  Market Morning: Shutdown Deal, Aurora Losses, Google Walmart Breakup, Turkish Hyperinflation Market Exclusive
06:15AM  Toys R Us 2.0: Does a Market Exist for Its Revival? Motley Fool
03:06AM  Stocks - EA Jumps in Premarket; Walmart, Amazon Rise; Gilead, Aurora Slump Investing.com
01:52AM  Exclusive: Walmart, Google-backed Deliv end online grocery partnership Reuters
Feb-11-19 04:37PM  Why the Rally in Fitbit Stock May Be on Its Last Legs InvestorPlace
04:37PM  Toys R Us plans second act by holiday season Associated Press
04:22PM  Home services site Handy has furniture assembly deal with Crate and Barrel Reuters
03:38PM  Toys R US plans second act under new name Associated Press
03:20PM  Buy These 5 Stocks to Play the Megatrend of the Century InvestorPlace
09:06AM  Costco's January Comps Growth Decelerates: Should You Worry? Zacks
08:32AM  Walmart Board of Directors Adds Cesar Conde, Chairman of NBCUniversal International Group and NBCUniversal Telemundo Enterprises Business Wire
07:50AM  Walmart launches private-label furniture collection online American City Business Journals
05:00AM  Amazon Has a Big Advertising Business. Walmart Wants One Too Bloomberg
03:29AM  Stocks - Tesla, Apple, Netflix, Restaurant Brands Rise in Premarket Investing.com
Feb-09-19 01:27PM  Shoplifter extortion case against Walmart, other retailers is dismissed Reuters
Feb-08-19 10:50PM  3 Things Under the Radar This Week Investing.com
05:33PM  Ron Johnson: Amazon should be having trouble sleeping at night Yahoo Finance Video
05:31PM  Walmart goes minimalist for new home goods line Yahoo Finance Video
04:27PM  Walmart Now Has Trendy Scandinavian Furniture With Launch of MoDRN TheStreet.com
01:56PM  Retailers turn to online sales for fresh food Yahoo Finance Video
08:22AM  Walmart launches home brand, MoDRN MarketWatch
01:00AM  Walmart's Plan B for Britain Bloomberg
Feb-07-19 04:29PM  Why Synchrony Financial Stock Jumped 28% in January Motley Fool
04:11PM  Walmex says same-store sales up 4.4 pct in January Reuters
03:03PM  Who are Amazon's (AMZN) main competitors? Investopedia
02:32PM  Fisher-Price recalls 44,000 Power Wheels Barbie Dream Campers American City Business Journals
Walmart Inc. engages in the retail and wholesale operations in various formats worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, discount stores, drugstores, and convenience stores; membership-only warehouse clubs; e-commerce Websites, such as walmart.com, jet.com, hayneedle.com, shoes.com, moosejaw.com, modcloth.com, bonobos.com, and samsclub.com; and mobile commerce and voice-activated commerce applications. The company offers grocery products, including meat, produce, natural and organics, deli and bakery, dairy, frozen foods, alcoholic and nonalcoholic beverages, floral and dry grocery, as well as consumables, such as health and beauty aids, baby products, household chemicals, paper goods, and pet supplies; and health and wellness products. It also provides electronics, cameras and supplies, photo processing services, wireless, movies, music, video games, and books; stationery, automotive, hardware and paint, sporting goods, and outdoor living and horticulture; apparel for women, girls, men, boys, and infants, as well as shoes, jewelry, and accessories; and home furnishings, housewares and small appliances, bedding, home decor, toys, fabrics, crafts, and seasonal merchandise, as well as brand name merchandise. In addition, the company offers fuel and financial services and related products, including money orders, prepaid cards, wire and money transfers, check cashing, and bill payment, as well as consumer credit services. It operates approximately 11,200 stores and various e-commerce Websites under the 55 banners in 27 countries. The company was formerly known as Wal-Mart Stores, Inc. and changed its name to Walmart Inc. in February 2018. It has strategic partnership with Microsoft Corporation. Walmart Inc. was founded in 1945 and is based in Bentonville, Arkansas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALTON S ROBSONDirectorDec 28Sale92.48734,95067,968,64540,603,858Dec 31 06:34 PM
WALTON JIM C10% OwnerDec 28Sale92.48734,95067,968,64540,603,858Dec 31 06:39 PM
WALTON ALICE L10% OwnerDec 28Sale92.48734,95067,968,64540,603,858Dec 31 06:41 PM
WALTON ALICE L10% OwnerDec 19Sale92.29500,50046,191,54541,338,808Dec 21 06:22 PM
WALTON JIM C10% OwnerDec 19Sale92.29500,50046,191,54541,338,808Dec 21 06:24 PM
WALTON S ROBSONDirectorDec 19Sale92.29500,50046,191,54541,338,808Dec 21 06:26 PM
WALTON ALICE L10% OwnerDec 17Sale92.0050046,00041,839,308Dec 19 05:07 PM
WALTON S ROBSONDirectorDec 17Sale92.0050046,00041,839,308Dec 19 05:10 PM
WALTON JIM C10% OwnerDec 17Sale92.0050046,00041,839,308Dec 19 05:12 PM
WALTON ALICE L10% OwnerDec 14Sale92.24298,72627,553,56042,812,808Dec 17 06:05 PM
WALTON JIM C10% OwnerDec 14Sale92.24298,72627,553,56042,812,808Dec 17 06:09 PM
WALTON S ROBSONDirectorDec 14Sale92.24298,72627,553,56042,812,808Dec 17 06:11 PM
WALTON ALICE L10% OwnerDec 13Sale93.01426,16039,637,95143,111,534Dec 17 06:05 PM
WALTON JIM C10% OwnerDec 13Sale93.01426,16039,637,95143,111,534Dec 17 06:09 PM
WALTON S ROBSONDirectorDec 13Sale93.01426,16039,637,95143,111,534Dec 17 06:11 PM
WALTON ALICE L10% OwnerDec 12Sale93.64844,37179,070,02543,537,694Dec 13 06:02 PM
WALTON S ROBSONDirectorDec 12Sale93.64844,37179,070,02543,537,694Dec 13 06:03 PM
WALTON JIM C10% OwnerDec 12Sale93.64844,37179,070,02543,537,694Dec 13 06:06 PM
WALTON ALICE L10% OwnerDec 11Sale93.99729,46968,564,30544,382,065Dec 13 06:02 PM
WALTON S ROBSONDirectorDec 11Sale93.99729,46968,564,30544,382,065Dec 13 06:03 PM
WALTON JIM C10% OwnerDec 11Sale93.99729,46968,564,30544,382,065Dec 13 06:06 PM
WALTON S ROBSONDirectorDec 04Sale97.50722,15670,413,10745,111,534Dec 06 06:50 PM
WALTON JIM C10% OwnerDec 04Sale97.50722,15670,413,10745,111,534Dec 06 06:52 PM
WALTON ALICE L10% OwnerDec 04Sale97.50722,15670,413,10745,111,534Dec 06 06:55 PM
WALTON S ROBSONDirectorDec 03Sale98.70387,00038,196,70745,833,690Dec 06 06:50 PM
WALTON JIM C10% OwnerDec 03Sale98.70387,00038,196,70745,833,690Dec 06 06:52 PM
WALTON ALICE L10% OwnerDec 03Sale98.70387,00038,196,70745,833,690Dec 06 06:55 PM
Furner John R.Executive Vice PresidentNov 28Sale97.344,000389,360161,405Nov 29 05:25 PM
WALTON JIM C10% OwnerNov 28Sale96.49275,00026,534,31046,484,690Nov 28 06:40 PM
WALTON S ROBSONDirectorNov 28Sale96.49275,00026,534,31046,484,690Nov 28 06:39 PM
WALTON ALICE L10% OwnerNov 28Sale96.49275,00026,534,31046,484,690Nov 28 06:42 PM
WALTON ALICE L10% OwnerNov 27Sale95.041,258,329119,593,14249,019,690Nov 28 06:42 PM
WALTON S ROBSONDirectorNov 27Sale95.041,258,329119,593,14249,019,690Nov 28 06:39 PM
WALTON JIM C10% OwnerNov 27Sale95.041,258,329119,593,14249,019,690Nov 28 06:40 PM
WALTON ALICE L10% OwnerNov 26Sale95.201,198,027114,050,72850,278,019Nov 28 06:42 PM
WALTON S ROBSONDirectorNov 26Sale95.201,198,027114,050,72850,278,019Nov 28 06:39 PM
WALTON JIM C10% OwnerNov 26Sale95.201,198,027114,050,72850,278,019Nov 28 06:40 PM
WALTON S ROBSONDirectorNov 21Sale94.11644,40560,643,24051,476,046Nov 23 05:12 PM
WALTON JIM C10% OwnerNov 21Sale94.11644,40560,643,24051,476,046Nov 23 05:09 PM
WALTON ALICE L10% OwnerNov 21Sale94.11644,40560,643,24051,476,046Nov 23 05:08 PM
WALTON S ROBSONDirectorNov 20Sale94.27706,76966,624,14552,120,451Nov 20 06:13 PM
WALTON JIM C10% OwnerNov 20Sale94.27706,76966,624,14552,120,451Nov 20 06:11 PM
WALTON ALICE L10% OwnerNov 20Sale94.27706,76966,624,14552,120,451Nov 20 06:08 PM
Canney Jacqueline PExecutive Vice PresidentNov 19Sale97.954,026394,34753,250Nov 20 05:02 PM
WALTON S ROBSONDirectorNov 19Sale97.15910,65688,468,95752,827,220Nov 20 06:13 PM
WALTON JIM C10% OwnerNov 19Sale97.15910,65688,468,95752,827,220Nov 20 06:11 PM
WALTON ALICE L10% OwnerNov 19Sale97.15910,65688,468,95752,827,220Nov 20 06:08 PM
WALTON S ROBSONDirectorNov 16Sale97.711,281,814125,243,08253,737,876Nov 20 06:13 PM
WALTON JIM C10% OwnerNov 16Sale97.711,281,814125,243,08253,737,876Nov 20 06:11 PM
WALTON ALICE L10% OwnerNov 16Sale97.711,281,814125,243,08253,737,876Nov 20 06:08 PM
WALTON JIM C10% OwnerSep 28Sale94.01420,95339,574,92855,019,690Sep 28 06:20 PM
WALTON S ROBSONDirectorSep 28Sale94.01420,95339,574,92855,019,690Sep 28 06:16 PM
Furner John R.Executive Vice PresidentSep 28Sale94.049,623904,964165,402Sep 28 06:29 PM
WALTON ALICE L10% OwnerSep 28Sale94.01420,95339,574,92855,019,690Sep 28 06:24 PM
WALTON ALICE L10% OwnerSep 27Sale94.46807,65476,290,83555,440,643Sep 28 06:24 PM
WALTON JIM C10% OwnerSep 27Sale94.46807,65476,290,83555,440,643Sep 28 06:20 PM
WALTON S ROBSONDirectorSep 27Sale94.46807,65476,290,83555,440,643Sep 28 06:16 PM
WALTON ALICE L10% OwnerSep 26Sale95.13781,18574,317,34156,248,297Sep 28 06:24 PM
WALTON JIM C10% OwnerSep 26Sale95.13781,18574,317,34156,248,297Sep 28 06:20 PM
WALTON S ROBSONDirectorSep 26Sale95.13781,18574,317,34156,248,297Sep 28 06:16 PM
WALTON ALICE L10% OwnerSep 18Sale95.37600,00057,223,14057,029,482Sep 20 06:51 PM
WALTON JIM C10% OwnerSep 18Sale95.37600,00057,223,14057,029,482Sep 20 06:48 PM
WALTON S ROBSONDirectorSep 18Sale95.37600,00057,223,14057,029,482Sep 20 06:46 PM
WALTON JIM C10% OwnerSep 13Sale95.23531,36050,600,08457,629,482Sep 17 06:19 PM
WALTON ALICE L10% OwnerSep 13Sale95.23531,36050,600,08457,629,482Sep 17 06:17 PM
WALTON S ROBSONDirectorSep 13Sale95.23531,36050,600,08457,629,482Sep 17 06:15 PM
WALTON JIM C10% OwnerSep 12Sale96.26430,64041,453,53658,708,682Sep 13 06:35 PM
WALTON S ROBSONDirectorSep 12Sale96.26430,64041,453,53658,708,682Sep 13 06:32 PM
WALTON ALICE L10% OwnerSep 12Sale96.26430,64041,453,53658,708,682Sep 13 06:29 PM
WALTON JIM C10% OwnerSep 11Sale96.92600,00058,154,78259,139,322Sep 13 06:35 PM
WALTON S ROBSONDirectorSep 11Sale96.92600,00058,154,78259,139,322Sep 13 06:32 PM
WALTON ALICE L10% OwnerSep 11Sale96.92600,00058,154,78259,139,322Sep 13 06:29 PM
McKenna Judith JExecutive Vice PresidentSep 06Sale96.3112,1111,166,352115,478Sep 07 05:48 PM
WALTON JIM C10% OwnerSep 05Sale95.71230,50022,060,02659,739,322Sep 07 05:46 PM
WALTON S ROBSONDirectorSep 05Sale95.71230,50022,060,02659,739,322Sep 07 05:43 PM
WALTON ALICE L10% OwnerSep 05Sale95.71230,50022,060,02659,739,322Sep 07 05:40 PM
Canney Jacqueline PExecutive Vice PresidentAug 31Sale95.481,575150,38857,276Aug 31 05:47 PM
Biggs M. BrettExecutive Vice PresidentAug 30Sale96.1418,4211,771,067185,557Aug 31 05:44 PM
WALTON ALICE L10% OwnerAug 24Sale95.09751,05471,418,80859,969,822Aug 24 07:39 PM
WALTON JIM C10% OwnerAug 24Sale95.09751,05471,418,80859,969,822Aug 24 07:37 PM
WALTON S ROBSONDirectorAug 24Sale95.09751,05471,418,80859,969,822Aug 24 07:34 PM
WALTON ALICE L10% OwnerAug 23Sale95.34525,00850,053,89563,520,876Aug 24 07:39 PM
WALTON JIM C10% OwnerAug 23Sale95.34525,00850,053,89563,520,876Aug 24 07:37 PM
WALTON S ROBSONDirectorAug 23Sale95.34525,00850,053,89563,520,876Aug 24 07:34 PM
WALTON JIM C10% OwnerAug 21Sale95.921,524,905146,267,36369,045,884Aug 23 05:50 PM
WALTON S ROBSONDirectorAug 21Sale95.921,524,905146,267,36369,045,884Aug 23 05:46 PM
WALTON ALICE L10% OwnerAug 21Sale95.921,524,905146,267,36369,045,884Aug 23 05:43 PM
Bartlett Daniel JExecutive Vice PresidentAug 20Sale96.252,883277,49786,381Aug 22 09:39 PM
WALTON ALICE L10% OwnerAug 20Sale96.17286,76227,578,70470,570,789Aug 21 06:01 PM
WALTON JIM C10% OwnerAug 20Sale96.17286,76227,578,70470,570,789Aug 21 05:59 PM
WALTON S ROBSONDirectorAug 20Sale96.17286,76227,578,70470,570,789Aug 21 05:57 PM
WALTON ALICE L10% OwnerAug 17Sale98.28594,39658,419,41270,857,551Aug 21 06:01 PM
WALTON JIM C10% OwnerAug 17Sale98.28594,39658,419,41270,857,551Aug 21 05:59 PM
WALTON S ROBSONDirectorAug 17Sale98.28594,39658,419,41270,857,551Aug 21 05:57 PM
Furner John R.Executive Vice PresidentAug 07Option Exercise89.673,236290,172175,161Aug 08 05:05 PM
WALTON S ROBSONDirectorJun 19Sale82.98550,95845,716,01674,426,947Jun 21 05:23 PM
WALTON JIM C10% OwnerJun 19Sale82.98550,95845,716,01674,426,947Jun 21 05:04 PM
WALTON ALICE L10% OwnerJun 19Sale82.98550,95845,716,01674,426,947Jun 21 04:58 PM
WALTON ALICE L10% OwnerJun 18Sale83.15510,89342,482,08175,137,905Jun 19 05:57 PM
WALTON JIM C10% OwnerJun 18Sale83.15510,89342,482,08175,137,905Jun 19 05:53 PM
NVS Novartis AG daily Stock Chart
NVS [NYSE]
Novartis AG
Index- P/E16.71 EPS (ttm)5.38 Insider Own9.30% Shs Outstand2.51B Perf Week1.16%
Market Cap225.23B Forward P/E16.46 EPS next Y5.46 Insider Trans-0.02% Shs Float2.51B Perf Month2.19%
Income12.61B PEG2.41 EPS next Q1.28 Inst Own12.30% Short Float0.09% Perf Quarter1.78%
Sales53.17B P/S4.24 EPS this Y66.90% Inst Trans5.47% Short Ratio0.88 Perf Half Y9.84%
Book/sh34.03 P/B2.64 EPS next Y5.06% ROA8.90% Target Price99.00 Perf Year5.10%
Cash/sh6.37 P/C14.11 EPS next 5Y6.94% ROE16.60% 52W Range72.30 - 92.39 Perf YTD4.74%
Dividend2.94 P/FCF40.71 EPS past 5Y7.70% ROI6.30% 52W High-2.72% Beta0.70
Dividend %3.27% Quick Ratio1.00 Sales past 5Y0.20% Gross Margin67.90% 52W Low24.32% ATR0.93
Employees125161 Current Ratio1.20 Sales Q/Q3.80% Oper. Margin15.40% RSI (14)61.63 Volatility0.74% 0.86%
OptionableYes Debt/Eq0.41 EPS Q/Q-37.10% Profit Margin23.70% Rel Volume0.97 Prev Close89.02
ShortableYes LT Debt/Eq0.29 EarningsJan 30 BMO Payout54.10% Avg Volume2.43M Price89.88
Recom1.00 SMA202.26% SMA503.27% SMA2008.05% Volume2,351,443 Change0.97%
Jan-02-19Downgrade JP Morgan Neutral → Underweight
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Underperform → Buy
May-29-18Downgrade HSBC Securities Buy → Hold
May-25-18Upgrade Credit Suisse Underperform → Neutral
Jan-25-18Reiterated Leerink Partners Outperform $93 → $100
Dec-06-17Downgrade BofA/Merrill Neutral → Underperform
Jul-26-17Upgrade Morgan Stanley Underweight → Overweight
Jul-05-17Downgrade Credit Suisse Neutral → Underperform
Mar-09-17Initiated Liberum Buy
Mar-08-17Upgrade Societe Generale Hold → Buy
Mar-07-17Downgrade Exane BNP Paribas Neutral → Underperform
Jan-11-17Downgrade Credit Suisse Outperform → Neutral
Nov-10-16Upgrade Argus Hold → Buy
Oct-10-16Reiterated Chardan Capital Markets Buy $95 → $92
Sep-20-16Initiated Chardan Capital Markets Buy $95
Apr-12-16Downgrade Morgan Stanley Equal-Weight → Underweight
Mar-23-16Downgrade Leerink Partners Outperform → Mkt Perform
Jun-22-15Upgrade Bryan Garnier Neutral → Buy
Feb-18-19 04:45PM  Novartis Positioned to Be World's Top Drug Seller in 2024 GuruFocus.com
11:20AM  Novartis-owned firm picks Durham over Illinois, Ireland American City Business Journals
Feb-15-19 04:40PM  U.S. Medicare plans to track CAR-T cancer therapy outcomes Reuters
04:12PM  Biogen Inc. -- Moody's announces completion of a periodic review of ratings of Biogen Inc. Moody's
02:16PM  Medicare would cover CAR-T therapies under new CMS proposal MarketWatch
Feb-14-19 01:49PM  Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat Zacks
10:50AM  The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia Zacks
07:50AM  The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial Benzinga
12:53AM  [$$] J&J and Novartis back cancer geneticists immunotherapy start-up Financial Times
Feb-13-19 03:36PM  Conatus (CNAT) Completes Enrollment in Phase II NASH Study Zacks
03:07PM  Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report Zacks
01:53PM  Clinigen agrees to buy U.S. rights to Novartis' cancer drug Proleukin Reuters
01:37PM  Top Research Reports for ExxonMobil, Merck & Danaher Zacks
01:34PM  Clinigen agrees to buy U.S. rights to Novartis' cancer drug Proleukin Reuters
Feb-12-19 06:29PM  Aduro Initiates Dosing in Phase I Melanoma Study on ADU-S100 Zacks
Feb-11-19 03:58PM  Is a Disappointment in Store for Incyte (INCY) Q4 Earnings? Zacks
11:09AM  The roots of servant leadership management culture date back to Hermann Hesse and a young Hillary Clinton Quartz
Feb-10-19 07:32PM  [$$] Big Pharmas Big Cancer Hope Is Fizzling The Wall Street Journal
Feb-08-19 04:56PM  Tilray (TLRY) to Report Q4 Earnings: What's in the Cards? Zacks
04:33PM  Incyte Down as FDA Extends Review Period of Jakafi for GVHD Zacks
08:03AM  Ligand (LGND) Beats on Q4 Earnings & Sales, Raises '19 View Zacks
Feb-07-19 09:57PM  Ligand Pharmaceuticals Inc (LGND) Q4 2018 Earnings Conference Call Transcript Motley Fool
09:00AM  Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19 Zacks
01:44AM  Novartis CEO lauds Trump administration plan to overhaul rebates Reuters
Feb-06-19 11:56PM  Novartis CEO says U.S. rebate plan will return cash to patients Reuters
06:03PM  Novartis CEO says U.S. rebate plan will return cash to patients Reuters
05:45PM  Novartis CEO says U.S. rebate plan will return cash to patients Reuters
07:47AM  Glaxo Inks Deal With Merck KGaA to Co-Develop Cancer Candidate Zacks
Feb-05-19 02:03PM  Array Biopharma Inc (ARRY) Q2 2019 Earnings Conference Call Transcript Motley Fool
12:40PM  Should You Buy Cronos Group Stock Right Now? InvestorPlace
12:14PM  Novartis's Alcon eye-care unit to enter Swiss index after spin off Reuters
09:02AM  Roche Submits sBLA to FDA for Label Expansion of Kadcyla Zacks
08:43AM  Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat Zacks
Feb-04-19 09:50AM  Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy Zacks
09:09AM  What's in the Cards for Glaxo (GSK) This Earnings Season? Zacks
05:24AM  [$$] Novartis Backs Lutathera Pricing After Price-Gouging Accusations The Wall Street Journal
Feb-01-19 05:58PM  Mylan's Generic Version of Advair Diskus Wins FDA Approval Zacks
04:50PM  Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance Zacks
01:30PM  Gene Therapy: Novartis Under The Microscope With Novel Treatment Investor's Business Daily
08:15AM  Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY Zacks
Jan-31-19 02:24PM  Novartis Posts Earnings, Revenue Miss GuruFocus.com
12:48PM  Novartis (NVS) Q4 Earnings Miss Estimates, Revenues Up Y/Y Zacks
Jan-30-19 11:45PM  Why are deep-pocketed biotechs cutting hundreds of jobs? American City Business Journals
04:42PM  Novartis Slides On Earnings Lag, But Sees 10 New Blockbusters By 2020 Investor's Business Daily
12:05PM  Despite Raising Prices, Big Pharma Is Selling Drugs for Less The Wall Street Journal
10:45AM  McDonalds posts earnings, Boeing has huge quarter, Novartis has a new plan Yahoo Finance
10:21AM  McDonalds posts earnings, Boeing has historical quarter, Novartis has a new plan Yahoo Finance Video
09:42AM  Novartis CEO sees 'further conversation' on Sandoz future in 18 months Reuters
08:37AM  Novartis 2019 growth outlook leaves investors wanting more Reuters
08:12AM  The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance Benzinga
07:28AM  A Cure for Cancer Next Year? The Stock Market Says Don't Believe the Hype Motley Fool
05:36AM  Novartis: 4Q Earnings Snapshot Associated Press
04:30AM  Novartis Misses Earnings and Sales Estimates in Q4 Zacks
03:23AM  [$$] Novartis's Bet on Higher-Value Drugs Pays Off The Wall Street Journal
01:59AM  [$$] Novartis forecasts mid-single digit sales growth in 2019 Financial Times
01:23AM  Novartis earnings narrowly miss expectations, shares down 2% CNBC
Jan-29-19 10:43AM  Allergan (AGN) Q4 Earnings Beat Estimates, 2019 View Tepid Zacks
Jan-28-19 04:15PM  How Novartis Could Throw A Haymaker And Slam Amgen's Sales Investor's Business Daily
04:17AM  Amgen (AMGN) to Report Q4 Earnings: What's in the Cards? Zacks
Jan-25-19 01:55PM  Davos 2019: Novartis CEO on company's focus Yahoo Finance Video
01:12PM  Novartis urges Britain to secure drug supplies before Brexit Reuters
Jan-24-19 04:34PM  Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings? Zacks
Jan-23-19 01:39PM  Why Tilray Stock Can Still Set Itself Apart From the Crowd InvestorPlace
Jan-22-19 07:58AM  Alnylam & Medison Partner to Market RNAi Products in Israel Zacks
Jan-21-19 01:33PM  Lilly Stops Lartruvo Promotion as Confirmatory Study Fails Zacks
Jan-20-19 09:21AM  3 Things You Need to Know About the FDA's Plan for Gene-Editing Drugs Motley Fool
Jan-17-19 09:30AM  NVS or AZN: Which Is the Better Value Stock Right Now? Zacks
Jan-16-19 04:48PM  Adamis stock surges on release of EpiPen alternative MarketWatch
04:19PM  Intrexon Signs Licensing Agreement with Next Green Wave Zacks
10:16AM  Tilray Teams Up With Authentic Brands, Stock Down on Sell-Off Zacks
09:25AM  6 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2019 Zacks
Jan-15-19 04:18PM  Here's How The Government Shutdown Will Affect These Medical Stocks Investor's Business Daily
Jan-14-19 04:02PM  Tilray Shares Rally as Investor Plans Not to Sell Shares Zacks
Jan-11-19 06:11PM  NASH Space in Focus in 2019 as Firms Look to Diversify Zacks
12:02PM  Will Tilrays Dealmaking Lift Tilray Stock in 2019? InvestorPlace
10:38AM  Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why Zacks
09:45AM  Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet Zacks
Jan-10-19 06:05AM  Novartis migraine drug not cost effective - U.K. price watchdog Reuters
Jan-09-19 02:01PM  Canopy Growth Moves to Key Resistance Investopedia
08:31AM  Novartis' Crizanlizumab Gets Breakthrough Therapy Status Zacks
Jan-08-19 10:11AM  Novartis Stock Is Poised to Rise Another 15% From Here TheStreet.com
08:15AM  The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase Benzinga
Jan-07-19 06:59PM  Cramer Remix: This chipmaker could have another bad quarterbut it's worth buying now CNBC
06:40PM  Novartis CEO on chasing cures over profitable treatments CNBC Videos
06:24PM  Novartis CEO talks chasing cures over profitable treatments, says they will 'ultimately' be valued CNBC
Jan-04-19 06:32PM  Tilray Gains More Than 200%: Is There More Scope for Growth? Zacks
04:24PM  These Stocks Pop After FDA Expedites Review Of Gene-Editing Therapy Investor's Business Daily
Jan-03-19 05:58PM  Verily lines up $1 billion investment American City Business Journals
03:49PM  Bristol-Myers' (BMY) Sprycel Gets FDA Nod for Label Expansion Zacks
10:27AM  Ironwood/Allergan Settle Linzess Patent Litigation With Mylan Zacks
10:12AM  Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019? Zacks
Dec-31-18 08:31AM  Novartis (NVS) Benefits From New Drugs & Key Acquisitions Zacks
Dec-28-18 05:40PM  Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan Zacks
Dec-27-18 09:39AM  Teva Stock Rises on Patent Settlement With Neos Therapeutics Zacks
08:20AM  Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019 Zacks
Dec-24-18 10:08AM  Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA Zacks
Dec-23-18 11:31AM  What Are the Best Marijuana Stocks? Motley Fool
Dec-21-18 04:26PM  Why Gene Therapy Is More Cost Effective Than Biogen's Approved Drug Investor's Business Daily
08:51AM  Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer Zacks
Dec-20-18 09:44PM  U.S body says gene therapy may be more cost effective for spinal muscular atrophy Reuters
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, and established medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas; and finished dosage form anti-infective. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The company's Alcon segment offers intraocular lenses and equipment for cataract procedures; equipment, instruments, and devices for vitreoretinal surgeries; surgical equipment and diagnostic devices for refractive surgical procedures; and devices to treat glaucoma. It also provides viscoelastics, surgical solutions, diagnostic ophthalmic products, surgical packs, and other disposable products for cataract and vitreoretinal surgery. In addition, this segment offers contact lenses and ocular health products; over-the-counter ophthalmic products; eye drops for the temporary relief of ocular itching due to allergies; vitamins for ocular health; and iLux Device, a therapeutic device used to treat meibomian gland dysfunction. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Ligand Pharmaceuticals, Inc.; Amgen; University of California, Berkeley; Bristol-Myers Squibb; IBM Watson Health; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; PEAR Therapeutics; Pfizer; and Conatus Pharmaceuticals Inc. The company was founded in 1895 and is headquartered in Basel, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novartis Bioventures Ltd10% OwnerAug 20Sale2.3020,38846,8922,396,882Aug 22 04:34 PM
Novartis Bioventures Ltd10% OwnerAug 20Sale3.905,30020,6705,800,250Aug 22 04:07 PM
Novartis Bioventures Ltd10% OwnerAug 17Sale2.108,70018,2702,417,270Aug 20 05:12 PM
Novartis Bioventures Ltd10% OwnerAug 16Sale2.108,80818,4972,425,970Aug 20 05:12 PM
Novartis Bioventures Ltd10% OwnerAug 15Sale2.152,6355,6652,434,778Aug 16 04:18 PM
Novartis Bioventures Ltd10% OwnerAug 14Sale2.263,3007,4582,437,413Aug 16 04:18 PM
Novartis Bioventures Ltd10% OwnerAug 13Sale2.361,6003,7762,440,713Aug 14 05:05 PM
Novartis Bioventures Ltd10% OwnerAug 10Sale2.445,61513,7012,442,313Aug 14 05:05 PM
Novartis Bioventures Ltd10% OwnerAug 09Sale2.482355832,447,928Aug 10 04:29 PM
Novartis Bioventures Ltd10% OwnerAug 08Sale2.781,0002,7802,448,163Aug 10 04:29 PM
Novartis Bioventures Ltd10% OwnerAug 07Sale2.971,7395,1652,449,163Aug 08 04:21 PM
Novartis Bioventures Ltd10% OwnerAug 06Sale3.022,9428,8852,450,902Aug 08 04:21 PM
Novartis Bioventures Ltd10% OwnerAug 02Sale3.334,70215,6582,453,844Aug 06 04:22 PM
Novartis Bioventures Ltd10% OwnerAug 01Sale3.228,18126,3432,458,546Aug 02 04:33 PM
Novartis Bioventures Ltd10% OwnerJul 31Sale3.074,50013,8152,466,727Aug 02 04:33 PM
Novartis Bioventures Ltd10% OwnerJul 30Sale3.272,0006,5402,471,227Jul 31 04:16 PM
Novartis Bioventures Ltd10% OwnerJul 27Sale3.386,45821,8282,473,227Jul 31 04:16 PM
Novartis Bioventures Ltd10% OwnerJul 26Sale3.637,93728,8112,479,685Jul 27 04:21 PM
Novartis Bioventures Ltd10% OwnerJul 25Sale3.8412,46047,8462,487,622Jul 27 04:21 PM
Novartis Bioventures Ltd10% OwnerJul 24Sale4.117002,8772,500,082Jul 25 04:35 PM
Novartis Bioventures Ltd10% OwnerJul 23Sale4.2530,600130,0502,500,782Jul 25 04:35 PM
Novartis Bioventures Ltd10% OwnerJul 17Sale4.7112,50058,8752,531,382Jul 18 04:17 PM
Novartis Bioventures Ltd10% OwnerJul 16Sale5.153001,5452,543,882Jul 18 04:17 PM
Novartis Institutes for BioMed10% OwnerApr 23Buy15.00766,66611,499,9903,948,482Apr 23 04:43 PM
CVS CVS Health Corporation daily Stock Chart
CVS [NYSE]
CVS Health Corporation
IndexS&P 500 P/E44.48 EPS (ttm)1.56 Insider Own0.10% Shs Outstand1.26B Perf Week6.95%
Market Cap87.54B Forward P/E9.39 EPS next Y7.41 Insider Trans-16.77% Shs Float1.26B Perf Month8.78%
Income1.60B PEG3.60 EPS next Q2.05 Inst Own77.00% Short Float1.15% Perf Quarter-13.95%
Sales188.06B P/S0.47 EPS this Y1.80% Inst Trans11.16% Short Ratio1.40 Perf Half Y-2.95%
Book/sh35.90 P/B1.94 EPS next Y6.41% ROA2.50% Target Price88.57 Perf Year-0.37%
Cash/sh33.12 P/C2.10 EPS next 5Y12.35% ROE8.30% 52W Range60.14 - 82.15 Perf YTD6.12%
Dividend2.00 P/FCF38.84 EPS past 5Y10.60% ROI9.90% 52W High-15.36% Beta1.00
Dividend %2.88% Quick Ratio1.90 Sales past 5Y8.50% Gross Margin15.60% 52W Low15.61% ATR1.49
Employees246000 Current Ratio2.40 Sales Q/Q2.40% Oper. Margin3.10% RSI (14)63.72 Volatility2.18% 1.93%
OptionableYes Debt/Eq1.72 EPS Q/Q8.10% Profit Margin1.60% Rel Volume0.99 Prev Close67.69
ShortableYes LT Debt/Eq1.66 EarningsFeb 20 BMO Payout65.50% Avg Volume10.30M Price69.53
Recom1.90 SMA205.84% SMA502.92% SMA200-1.31% Volume10,245,409 Change2.72%
Jan-17-19Initiated UBS Buy $75
Dec-18-18Initiated Barclays Overweight $91
Nov-29-18Resumed Goldman Neutral $87
Nov-28-18Initiated Evercore ISI Outperform $89
Oct-26-18Resumed Wolfe Research Peer Perform
Jul-09-18Upgrade Citigroup Neutral → Buy
Feb-27-18Resumed BofA/Merrill Buy
Feb-13-18Reiterated Citigroup Neutral $80 → $77
Jan-30-18Upgrade Needham Buy → Strong Buy $88 → $100
Jan-08-18Reiterated Leerink Partners Outperform $82 → $90
Jan-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-04-18Upgrade Raymond James Outperform → Strong Buy
Jan-02-18Reiterated Needham Buy $85 → $88
Dec-04-17Reiterated Needham Buy $79 → $85
Dec-04-17Initiated Deutsche Bank Buy $90
Nov-10-17Upgrade Needham Hold → Buy $79
Sep-19-17Initiated RBC Capital Mkts Outperform $95
Sep-15-17Reiterated Jefferies Hold $82 → $86
Aug-25-17Initiated Loop Capital Hold
Jun-28-17Initiated Needham Hold
Feb-18-19 01:27PM  Walgreens and CVS are redesigning their drugstores to focus more on health. Here's how they compare CNBC
11:59AM  What to Expect When Walmart and CVS Report Earnings This Week TheStreet.com
09:35AM  Should Value Investors Pick CVS Health (CVS) Stock Now? Zacks
09:09AM  Is CVS Health Corporation (NYSE:CVS) A Smart Pick For Income Investors? Simply Wall St.
08:04AM  What's in the Cards for Genomic Health (GHDX) in Q4 Earnings? Zacks
08:00AM  CVS's New HealthHub Program Aims to Reinvent the Corner Drugstore Motley Fool
07:37AM  Is Deep Value ETF (DVP) a Strong ETF Right Now? Zacks
Feb-15-19 06:47PM  Cramer's game plan: Investors shouldn't underestimate the importance of a trade deal with China CNBC
05:32PM  3 Things to Know About Q4 Earnings Season Zacks
02:42PM  Triad office buildings sell for $25 million American City Business Journals
12:00PM  CVS Health to Present at the SVB Leerink Global Healthcare Conference PR Newswire
08:59AM  Can Dental Growth Drive Henry Schein's (HSIC) Q4 Earnings? Zacks
08:54AM  Key Factors Likely to Shape CVS Health's (CVS) Q4 Earnings Zacks
08:06AM  IIROC Trading Halt - CVS.P; SEW.H CNW Group
07:50AM  Factors of Influence in 2019, Key Indicators and Opportunity within CVS Health, Solaris Oilfield Infrastructure, SK Telecom Co., Energizer, Emergent Biosolutions, and Quad Graphics New Research Emphasizes Economic Growth GlobeNewswire
Feb-14-19 07:21PM  Big hedge funds dumped China stocks, Apple as market tumbled Reuters
08:07AM  Here's What Will Give Shape to Medtronic's (MDT) Q3 Earnings Zacks
Feb-13-19 05:23PM  What to Expect from CVS Health's Q4 Earnings, Revenue & Comps Zacks
10:31AM  CVS Health (CVS) Earnings Expected to Grow: Should You Buy? Zacks
09:19AM  UnitedHealth Stock Is a Buy, but Keep an Eye on the External Risks InvestorPlace
09:16AM  Ford issues 3 recalls covering about 1.5 million Ford and Lincoln vehicles, some over potential whiplash concerns CNBC
09:06AM  Johnson & Johnson to buy Auris Health for $3.4 billion CNBC
06:09AM  CVS Health shows off new HealthHUB store design in Houston. Makeover includes dietitians, wellness rooms for yoga CNBC
Feb-12-19 09:00AM  Aetna Foundation, American Public Health Association and the National Association of Counties Unveil Winners of National Health Challenge PR Newswire
Feb-11-19 06:12PM  Comp Experts: CEO Pay Ratio Triggered Fresh Investor Questions, Possible Legislation CorpGov.com
05:45PM  CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know Zacks
Feb-08-19 12:00PM  CVS Health Corporation To Hold Fourth Quarter 2018 Conference Call PR Newswire
01:41AM  Stocks - U.S. Futures Fall on Trade Worry; Wells Fargo Eyed After Outage Investing.com
Feb-07-19 11:43AM  4 Health-Care Stocks With Yields Above 2% Barrons.com
Feb-06-19 05:23PM  Vanguard Health Care Fund Boosts CVS Health, Allergan GuruFocus.com
10:09AM  Chicago pharma company that raised drug price by 40 times now bankrupt American City Business Journals
08:54AM  Procter & Gamble to Widen Naturals Line With This is L. Buyout Zacks
Feb-05-19 05:48PM  Wellcare Health Plans Inc (WCG) Q4 2018 Earnings Conference Call Transcript Motley Fool
05:45PM  CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know Zacks
Feb-04-19 05:15PM  Cvs Health Corp (CVS) President and CEO Larry J Merlo Sold $10.7 million of Shares GuruFocus.com
10:10AM  Why the Earnings Surprise Streak Could Continue for CVS Health (CVS) Zacks
08:00AM  CVS Health Offering No Cost Heart Health Screenings This Valentine's Day In Support of Women's Heart Health PR Newswire
03:33AM  Healthcare wearables level up with new moves from Apple and Alphabet TechCrunch
Feb-02-19 10:07AM  Lightning Strikes the Least Popular Middlemen in Healthcare Motley Fool
Feb-01-19 03:59PM  Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva Reuters
02:16PM  The Latest News on CVS Stock Is Much Ado About Nothing InvestorPlace
11:38AM  US STOCKS-Wall St edges higher after strong jobs data; Amazon drags Reuters
10:09AM  US STOCKS-S&P near 8-week high after upbeat jobs data; Amazon results weigh Reuters
07:32AM  Dow Jones Futures: Amazon.com, CVS Lead Key Movers As Jobs Report Looms Investor's Business Daily
Jan-31-19 04:52PM  U.S. government proposes rule changing drug industry rebate system Reuters
12:57PM  The Eaton Vance Fund Exits Aetna, Bristol Myers GuruFocus.com
Jan-30-19 08:07PM  Anthem (ANTM) Q4 2018 Earnings Conference Call Transcript Motley Fool
01:57PM  Anthem Cheaply Copies Rivals $122 Billion Strategy Bloomberg
11:00AM  CVS Health Expanding Free Wellness Screenings Statewide in California PR Newswire
09:59AM  Is There Now An Opportunity In CVS Health Corporation (NYSE:CVS)? Simply Wall St.
Jan-29-19 05:45PM  CVS Health (CVS) Gains As Market Dips: What You Should Know Zacks
03:16PM  Skip the dentist's office: Walgreens and CVS are offering ways to fix your teeth in their stores CNBC
01:24PM  Apple partners with Aetna to launch health app leveraging Apple Watch data TechCrunch
12:28PM  Apple and Aetna team up for personalized health-tracking app Engadget
05:19AM  Apple Watch, using Aetna client data, wants to help you be healthy Reuters
05:11AM  Apple Watch, using Aetna client data, wants to help you be healthy Reuters
05:00AM  Apple and Aetna are teaming up on a new app to help track and reward healthy behavior CNBC
05:00AM  Aetna Announces Attain, a Personalized Well-being Experience that Combines Health History with Apple Watch Information to Empower Better Health PR Newswire
Jan-28-19 09:37PM  [$$] Apple and Aetna team up on new healthcare app Financial Times
06:49PM  Cramer's lightning round: CVS is 'one of the absolute cheapest stocks' in the market CNBC
02:52PM  Risk-Reward With CVS GuruFocus.com
Jan-25-19 03:43PM  Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen Reuters
08:59AM  CVS eliminates 70 percent of retouched images American City Business Journals
Jan-24-19 04:30PM  CVS Health Announces Transaction With Vitality Re X PR Newswire
01:21PM  Aetna, other health insurers team up with IBM on blockchain project Reuters
12:49PM  Aetna, other health insurers team up with IBM on blockchain project Reuters
09:30AM  CVS Pharmacy Unveils New Beauty Aisles Reflecting Significant Progress in Commitment to Transparency and New Standards for Beauty Imagery PR Newswire
09:00AM  CVS unveils 'Beauty Marks' in stores, warning shoppers of edited images Reuters
Jan-23-19 05:45PM  CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know Zacks
08:30AM  CVS Health's Accordant Awarded NCQA Accreditation for Case Management PR Newswire
Jan-22-19 09:21AM  CVS Health Named One of "World's Most Admired Companies" by FORTUNE Magazine for Fifth Consecutive Year PR Newswire
07:54AM  CVS Health's PBM Pharmacy Platform to Ride on Walmart Deal Zacks
Jan-21-19 07:57AM  Zacks.com featured expert Kevin Matras highlights: American Airlines, ArcBest, AmerisourceBergen, Cardinal Health and CVS Health Zacks
Jan-20-19 11:51AM  Bulls & Bears Of The Week: CVS, EA, GM, Kinder Morgan And More Benzinga
Jan-19-19 07:06AM  Better Buy: Walgreens Boots Alliance vs. CVS Health Motley Fool
Jan-18-19 07:52PM  Marching Toward the Madness Barrons.com
07:41PM  [$$] CVS Health Settles Pricing Fight With Walmart The Wall Street Journal
06:42PM  CVS Reaches Pharmacy Benefits Management System Deal with Walmart TheStreet.com
04:28PM  VF, CVS Health and JB Hunt jump while Netflix falls Associated Press
01:37PM  Will Health Insurers Subsidize the Apple Watch? Motley Fool
12:43PM  Health care, retail, biotech & emerging markets in the bl... CNBC Videos
10:39AM  Walmart and CVS ink a deal, American Express falls short, Apple partners with pharma giant Yahoo Finance
09:37AM  Stocks Jump On China Trade Hopes; Dow Jones Oil Giant Gets Upgrade Investor's Business Daily
09:25AM  CVS And Walmart Extend PBM, Managed Medicaid Agreement Benzinga
08:33AM  CVS, Walmart resolve pharmacy contract impasse Reuters
08:10AM  Walmart, CVS Health hammer out new PBM pharmacy network deal Associated Press
08:09AM  5 Stocks in Focus After Recent Broker Rating Upgrades Zacks
08:02AM  CVS, Walmart reach agreement on pharmacy contract after impasse Reuters
07:59AM  Stocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & more CNBC
07:07AM  [$$] CVS Health Settles Pricing Fight With Walmart The Wall Street Journal
06:42AM  CVS's stock jumps after deal to keep Walmart participating in PBM networks MarketWatch
06:30AM  CVS Health and Walmart Announce New PBM Pharmacy Network Agreement PR Newswire
Jan-17-19 03:24PM  UnitedHealth Is a Steady Investment for the Patient Investor InvestorPlace
Jan-16-19 03:04PM  3 Healthcare Stocks That Will Keep Your Portfolio Healthy InvestorPlace
09:32AM  Company News For Jan 16, 2019 Zacks
08:39AM  Amazon Fear Grips Retail Pharmacy Space, Alliances Continue Zacks
Jan-15-19 08:27PM  Walmart Could Leave CVS Caremark Pharmacy Networks Amid Dispute The Wall Street Journal
06:56PM  Apple should buy private digital health records operation... CNBC Videos
05:37PM  Raymond James: CVS A Strong Buy Despite Pricing Headwinds Benzinga
04:46PM  Walmart Could Leave CVS Caremark Pharmacy Networks Amid Dispute The Wall Street Journal
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y mas, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MERLO LARRY JPresident and CEOJan 08Option Exercise45.07166,3687,498,206496,577Jan 10 04:26 PM
MERLO LARRY JPresident and CEOJan 08Sale69.04166,36811,486,047330,209Jan 10 04:26 PM
Denton David MEVP and CFONov 29Sale80.1325,1592,015,991403Nov 30 04:59 PM
Brennan Troyen AEVP and Chief Medical OfficerNov 14Sale82.0014,2291,166,77870,494Nov 16 04:19 PM
Bisaccia LisaEVP and Chief HR OfficerOct 01Option Exercise51.1221,5341,100,80234,856Oct 03 04:07 PM
Boratto Eva CEVP, Cont & Chief Acct OfficerOct 01Option Exercise54.534,426241,35046,277Oct 03 04:09 PM
Boratto Eva CEVP, Cont & Chief Acct OfficerOct 01Sale80.004,426354,08041,851Oct 03 04:09 PM
Bisaccia LisaEVP and Chief HR OfficerOct 01Sale80.0021,5341,722,72021,086Oct 03 04:07 PM
Boratto Eva CEVP, Cont & Chief Acct OfficerSep 17Option Exercise45.0713,311599,92755,162Sep 19 04:26 PM
Boratto Eva CEVP, Cont & Chief Acct OfficerSep 17Sale77.1613,3111,027,07741,851Sep 19 04:26 PM
Hourican KevinEVP & President, CVS PharmacyAug 27Option Exercise54.534,426241,35012,135Aug 29 04:37 PM
Hourican KevinEVP & President, CVS PharmacyAug 27Sale75.008,564642,3003,571Aug 29 04:37 PM
DORMAN DAVID WDirectorMay 04Buy62.2224,3001,511,868104,638May 07 10:20 AM
BROWN C DAVID IIDirectorMay 04Buy61.9910,000619,900101,252May 07 10:17 AM
ABBV AbbVie Inc. daily Stock Chart
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E21.74 EPS (ttm)3.72 Insider Own0.07% Shs Outstand1.50B Perf Week1.48%
Market Cap121.12B Forward P/E8.57 EPS next Y9.43 Insider Trans-21.10% Shs Float1.49B Perf Month-5.49%
Income5.69B PEG2.29 EPS next Q2.05 Inst Own72.60% Short Float1.70% Perf Quarter-8.35%
Sales32.75B P/S3.70 EPS this Y-2.40% Inst Trans0.60% Short Ratio3.59 Perf Half Y-17.03%
Book/sh-1.92 P/B- EPS next Y8.57% ROA9.60% Target Price92.71 Perf Year-28.50%
Cash/sh5.86 P/C13.79 EPS next 5Y9.51% ROE- 52W Range75.77 - 122.00 Perf YTD-12.30%
Dividend4.28 P/FCF19.85 EPS past 5Y1.20% ROI17.80% 52W High-33.73% Beta1.17
Dividend %5.29% Quick Ratio1.10 Sales past 5Y9.00% Gross Margin76.40% 52W Low6.70% ATR1.94
Employees30000 Current Ratio1.20 Sales Q/Q249.50% Oper. Margin31.00% RSI (14)46.52 Volatility1.53% 2.44%
OptionableYes Debt/Eq- EPS Q/Q387.90% Profit Margin19.60% Rel Volume0.88 Prev Close80.52
ShortableYes LT Debt/Eq- EarningsJan 25 BMO Payout72.90% Avg Volume7.05M Price80.85
Recom2.70 SMA20-0.91% SMA50-5.23% SMA200-12.16% Volume6,295,419 Change0.41%
Jan-23-19Initiated UBS Neutral $91
Jan-03-19Downgrade BofA/Merrill Buy → Neutral
Dec-26-18Initiated Standpoint Research Buy
Oct-22-18Reiterated SunTrust Buy $157 → $135
Oct-04-18Reiterated BofA/Merrill Buy $107 → $106
Jun-01-18Downgrade Piper Jaffray Overweight → Neutral
May-30-18Downgrade Credit Suisse Neutral → Underperform
Jan-30-18Reiterated Morgan Stanley Equal-Weight $99 → $131
Jan-29-18Downgrade Leerink Partners Outperform → Mkt Perform
Oct-30-17Reiterated Leerink Partners Outperform $108 → $107
Oct-02-17Upgrade Leerink Partners Mkt Perform → Outperform
Sep-25-17Downgrade UBS Buy → Neutral $79 → $92
Aug-17-17Initiated Evercore ISI Outperform $95
Jun-22-17Upgrade Societe Generale Hold → Buy
Mar-22-17Upgrade Societe Generale Sell → Hold
Oct-31-16Downgrade Credit Suisse Outperform → Neutral
Oct-18-16Initiated Leerink Partners Mkt Perform $70
Sep-08-16Downgrade JP Morgan Overweight → Neutral
Sep-02-16Initiated Raymond James Outperform $82
Jun-08-16Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-18-19 05:00AM  Investors Miss the Mark on AbbVie's Strong Pipeline MoneyShow
Feb-16-19 10:04AM  These 3 Value Stocks Are Absurdly Cheap Right Now Motley Fool
Feb-15-19 04:16PM  AbbVie Inc. -- Moody's announces completion of a periodic review of ratings of AbbVie Inc. Moody's
08:01AM  [$$] WSJ Tax Guide 2019: The Drug Industry The Wall Street Journal
Feb-13-19 09:15AM  AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy? Zacks
Feb-12-19 09:11AM  AbbVie Buys Rights to Novel Immunotherapy for Multiple Myeloma Zacks
05:00AM  5 Aristocrats for Stable Income MoneyShow
Feb-11-19 03:24PM  5 High-Growth Stocks Undervalued by the Market InvestorPlace
02:46PM  Here's Why Coherus BioSciences Rose 48.7% in January Motley Fool
08:00AM  AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma PR Newswire
Feb-09-19 09:00AM  Here's Why AbbVie's Stock Tanked in January Motley Fool
Feb-08-19 01:58PM  Does FedEx look good here? What's the deal with McKesson? Buy Abbvie? CNBC Videos
Feb-06-19 08:43PM  Enanta Pharmaceuticals Inc (ENTA) Q1 2019 Earnings Conference Call Transcript Motley Fool
05:52PM  At least four pharma CEOs to testify at Senate drug pricing hearing Reuters
01:33PM  At least four pharma CEOs to testify at Senate drug pricing hearing Reuters
12:16PM  Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying CNBC
Feb-05-19 08:01PM  Flip the Script: Drugmakers Blame Middlemen for Price Increases The Wall Street Journal
04:06PM  Merck CEO Frazier to testify at Senate drug pricing hearing Reuters
03:02PM  3 Biotech Stocks That Pay Solid Dividends InvestorPlace
12:00PM  3 Red-Hot Stocks (And 3 That Arent) InvestorPlace
11:38AM  Pharma execs will testify before Congress 'one way or another,' US senator says CNBC
10:53AM  Top Marijuana Stocks That Pay Dividends Investopedia
08:07AM  Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies Zacks
06:00AM  Flip the Script: Drugmakers Blame Middlemen for Price Increases The Wall Street Journal
12:30AM  Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm PR Newswire
Feb-04-19 07:31AM  AbbVie Falls 3% Investing.com
Feb-03-19 10:40AM  Bulls & Bears Of The Week: AT&T, Facebook, GE, Microsoft And More Benzinga
09:06AM  Is AbbVie a Buy? Motley Fool
Feb-02-19 02:17PM  Pricing Pressure a Hard Pill for Pharma to Swallow Barrons.com
07:33AM  Better Buy: Johnson & Johnson vs. AbbVie Motley Fool
Feb-01-19 04:50PM  Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance Zacks
08:52AM  The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics Zacks
08:15AM  Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY Zacks
05:00AM  The 12 Best Dividend Aristocrats- Part 1 MoneyShow
Jan-31-19 12:39PM  Top Research Reports for Union Pacific, AbbVie & General Dynamics Zacks
Jan-30-19 10:19AM  ABBV Stock Is Worth a Look at Multi-Year Lows InvestorPlace
09:49AM  Genentech kills big drug study in early Alzheimer's patients American City Business Journals
08:16AM  3 Big Pharmas Expecting a Softer 2019 Motley Fool
07:16AM  Jim Cramer Gives His Opinion On AbbVie, Idexx Labs And More Benzinga
Jan-29-19 10:54PM  Edited Transcript of ABBV earnings conference call or presentation 25-Jan-19 2:00pm GMT Thomson Reuters StreetEvents
06:55PM  Cramer's lightning round: AbbVie needs to make an acquisitionit might just save its stock CNBC
05:45PM  AbbVie (ABBV) Gains As Market Dips: What You Should Know Zacks
03:48PM  10 Value Stocks to Buy for 2019 and Beyond Kiplinger
12:29PM  Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks
10:42AM  Jacksonville's increasing use of LNG as a transportation fuel American City Business Journals
10:00AM  3 Top Dividend Stocks to Buy Right Now Motley Fool
09:15AM  AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting Zacks
07:25AM  The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive Benzinga
Jan-28-19 12:10PM  Is AbbVie in Hot Water? GuruFocus.com
10:59AM  Analysts Cut AbbVie Price Targets After Earnings Miss Benzinga
10:19AM  Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB & AGN Zacks
10:07AM  The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck Zacks
09:15AM  This is Why AbbVie (ABBV) is a Great Dividend Stock Zacks
07:00AM  AbbVie Announces U.S. FDA Approval of IMBRUVICA® (ibrutinib) Plus Obinutuzumab (GAZYVA®) - First Chemotherapy-Free, Anti-CD20 Combination Regimen Approved for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in Previously Untreated Patients PR Newswire
05:38AM  AbbVie Falls 3% Investing.com
Jan-27-19 07:16PM  3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore Motley Fool
07:03AM  Forget Humira -- Here's What You Need to Know About AbbVie Motley Fool
Jan-25-19 04:37PM  Western Digital, Starbucks rise while AbbVie, Intel drop Associated Press -6.22%
04:35PM  Why Intel, AbbVie, and Vale Slumped Today Motley Fool
04:17PM  AbbVie Stock Crumbles After Biosimilars Take A Chunk Of Humira Sales Investor's Business Daily
04:10PM  AbbVie Falls After Missing Top- and Bottom-Line Estimates TheStreet.com
02:15PM  AbbVie Inc (ABBV) Q4 2018 Earnings Conference Call Transcript Motley Fool
01:45PM  AbbVie Q4 Earnings: 3 Key Things You Need to Know Motley Fool
12:00PM  Celgene Stock Is Rising After the CEO of AbbVie Ruled Out a Big Deal Barrons.com
11:15AM  [$$] Drug Maker AbbVie Swings to Loss on Charge from Stemcentrx Deal The Wall Street Journal
11:05AM  AbbVie Earnings: ABBV Stock Falters on Q4 Miss InvestorPlace
11:05AM  AbbVie expects steeper decline in Humira's overseas sales; shares fall Reuters
10:41AM  Congressional Activities on Shutdown in Focus Zacks
10:34AM  AbbVie (ABBV) Misses on Q4 Earnings & Revenues, Shares Down Zacks
10:28AM  Asia, Congress Activity, Put Futures in the Green Zacks
10:23AM  Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV Zacks
09:44AM  AbbVie not contemplating big deals - CEO Reuters
09:03AM  US STOCKS-Wall St set to open higher as investors focus on upbeat earnings Reuters
09:02AM  AbbVie (ABBV) Misses Q4 Earnings and Revenues, Shares Down Zacks
09:00AM  AbbVie (ABBV) Lags Q4 Earnings and Revenue Estimates Zacks
08:00AM  AbbVie: 4Q Earnings Snapshot Associated Press
07:52AM  Abbvie shares slide 2.3% premarket after earnings miss MarketWatch
07:49AM  AbbVie profit misses as Humira faces biosimilar challenge in Europe Reuters
07:45AM  AbbVie profit misses as Humira faces biosimilar challenge in Europe Reuters
07:42AM  AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results PR Newswire
02:46AM  AbbVie Earnings, Revenue miss in Q4 Investing.com
Jan-24-19 07:29PM  Can Allergan (AGN) Keep the Earnings Streak Alive in Q4? Zacks
04:34PM  Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings? Zacks
02:02PM  Q4 Earnings Preview For AbbVie Benzinga
01:00PM  What's Behind the Biotech ETF Rally to Start 2019? Zacks
11:17AM  Pfizer (PFE) to Report Q4 Earnings: What's in the Cards? Zacks
10:59AM  Healthcare ETFs in Focus Ahead of Q4 Earnings Zacks
10:47AM  The Zacks Analyst Blog Highlights: Amazon, Verizon, AbbVie, Lowe???s and Chubb Zacks
10:44AM  Zacks Investment Ideas feature highlights: International Business Machines, Procter and Gamble, Ford, Intel and Abbvie Zacks
10:27AM  Is a Surprise Coming for AbbVie (ABBV) This Earnings Season? Zacks
08:15AM  3 Things to Expect in AbbVie's Q4 Earnings Update Motley Fool
08:13AM  AbbVie Falls 3% Investing.com
Jan-23-19 02:32PM  Top Research Reports for Amazon, Verizon & AbbVie Zacks
09:31AM  Is a Beat in Store for AbbVie (ABBV) This Earnings Season? Zacks
Jan-22-19 11:22AM  5 Amazing Earnings Charts Zacks
09:57AM  J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft Zacks
08:31AM  Bet on These 5 Low Leverage Stocks to Secure Returns Zacks
06:06AM  Better Buy: Pfizer vs. AbbVie Motley Fool
Jan-21-19 02:08PM  AbbVie's Imbruvica Fails in Phase III Pancreatic Cancer Study Zacks
08:23AM  Zacks Value Trader Highlights: Crocs, Five Below, AbbVie and J.Jill Zacks
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune diseases; IMBRUVICA, an oral therapy for treating chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid for hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product for human use; and ZINBRYTA, a treatment for relapsing forms of multiple sclerosis. It serves wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers. AbbVie Inc. has collaborations with Alector, Inc.; C2N Diagnostics; Voyager Therapeutics, Inc.; Janssen Biotech, Inc.; International Myeloma Foundation; Calibr and Scripps Research; The Institute for Research in Immunology and Cancer Commercialization of Research; the Universite de Montreal; Tolero Pharmaceuticals, Inc.; Galapagos; Mission Therapeutics Ltd; Bristol-Myers Squibb Company; Voluntis; and Tizona Therapeutics, Inc. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schumacher Laura JVice ChairmanDec 28Sale90.0025,0002,250,000134,322Jan 02 04:49 PM
CHASE WILLIAM JEVP, Finance & AdministrationDec 12Sale90.0060,0005,400,000104,863Dec 14 05:12 PM
GONZALEZ RICHARD AChairman of the Board and CEODec 11Sale88.7516,8501,495,438286,203Dec 13 04:56 PM
Schumacher Laura JExecutive Vice PresidentDec 04Option Exercise51.4294,1404,840,679192,398Dec 07 05:15 PM
Schumacher Laura JExecutive Vice PresidentDec 04Sale93.5894,1408,809,55298,258Dec 07 05:15 PM
Gosebruch Henry OEVP, Chief Strategy OfficerNov 29Sale90.1042,4503,824,94030,350Nov 30 05:22 PM
SEVERINO MICHAELEVP, R&D and CSOAug 17Sale97.5250,0004,876,06082,281Aug 21 04:58 PM
TILTON GLENN FDirectorJun 27Buy91.905,400496,27439,735Jun 29 02:30 PM
RAPP EDWARD JDirectorJun 20Buy98.631,01399,90920,743Jun 22 05:56 PM
ALBAN CARLOSEVP, Commercial OperationsMar 01Option Exercise29.2348,1001,405,795178,547Mar 02 05:29 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 01Option Exercise25.9132,400839,339197,263Mar 02 05:28 PM
ALBAN CARLOSEVP, Commercial OperationsMar 01Sale114.3980,9959,264,80897,552Mar 02 05:29 PM
Schumacher Laura JExecutive Vice PresidentMar 01Sale117.8525,0002,946,14898,317Mar 02 05:28 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 01Sale114.5032,4003,709,687164,863Mar 02 05:28 PM
Michael Robert A.VP, ControllerFeb 28Sale119.434,294512,8536,876Mar 02 05:31 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 28Sale117.771,337157,45893,312Mar 02 05:31 PM
SEVERINO MICHAELEVP, R&D and CSOFeb 28Sale117.932,643311,684132,281Mar 02 05:30 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 28Sale118.6718,1292,151,45217,588Mar 02 05:30 PM
CHASE WILLIAM JEVP, Chief Financial OfficerFeb 28Sale119.4438,5284,601,954164,863Mar 02 05:28 PM
ALBAN CARLOSEVP, Commercial OperationsFeb 28Sale117.852,579303,928130,447Mar 02 05:29 PM
GONZALEZ RICHARD AChairman of the Board and CEOFeb 28Sale117.888,280976,084313,012Mar 02 05:28 PM
Michael Robert A.VP, ControllerFeb 20Sale120.31992119,35113,557Feb 20 06:08 PM
MMM 3M Company daily Stock Chart
MMM [NYSE]
3M Company
IndexDJIA S&P500 P/E22.72 EPS (ttm)9.19 Insider Own0.10% Shs Outstand580.70M Perf Week4.52%
Market Cap121.29B Forward P/E18.05 EPS next Y11.57 Insider Trans-13.85% Shs Float574.79M Perf Month10.23%
Income5.53B PEG3.19 EPS next Q2.56 Inst Own68.60% Short Float1.62% Perf Quarter5.29%
Sales32.77B P/S3.70 EPS this Y0.10% Inst Trans-0.64% Short Ratio3.78 Perf Half Y3.71%
Book/sh16.87 P/B12.38 EPS next Y8.66% ROA14.30% Target Price203.29 Perf Year-9.97%
Cash/sh5.57 P/C37.51 EPS next 5Y7.12% ROE51.70% 52W Range176.87 - 244.86 Perf YTD9.61%
Dividend5.76 P/FCF72.67 EPS past 5Y6.40% ROI23.50% 52W High-14.70% Beta1.04
Dividend %2.76% Quick Ratio1.30 Sales past 5Y1.20% Gross Margin49.10% 52W Low18.09% ATR3.83
Employees93516 Current Ratio1.90 Sales Q/Q-0.60% Oper. Margin22.00% RSI (14)64.13 Volatility1.57% 1.72%
OptionableYes Debt/Eq1.49 EPS Q/Q5.20% Profit Margin16.30% Rel Volume0.81 Prev Close204.93
ShortableYes LT Debt/Eq1.37 EarningsJan 29 BMO Payout59.80% Avg Volume2.45M Price208.86
Recom2.70 SMA205.08% SMA506.98% SMA2003.99% Volume2,000,378 Change1.92%
Oct-12-18Initiated Gordon Haskett Buy
Oct-12-18Initiated Credit Suisse Outperform
Aug-21-18Initiated Morgan Stanley Equal-Weight $212
May-16-18Downgrade Jefferies Buy → Hold
May-03-18Upgrade RBC Capital Mkts Sector Perform → Outperform $238
Apr-03-18Reiterated Stifel Hold $251 → $225
Feb-15-18Initiated Barclays Underweight $235
Feb-13-18Upgrade Deutsche Bank Hold → Buy $240 → $275
Jan-24-18Upgrade Hilliard Lyons Neutral → Buy
Jan-23-18Initiated UBS Neutral
Jan-18-18Reiterated JP Morgan Underweight $208 → $221
Jan-16-18Reiterated Citigroup Buy $268 → $278
Jan-10-18Reiterated Deutsche Bank Hold $180 → $240
Oct-25-17Upgrade Goldman Sell → Neutral $194 → $229
Oct-25-17Reiterated Stifel Hold $220 → $244
Oct-25-17Reiterated RBC Capital Mkts Sector Perform $205 → $209
Oct-02-17Reiterated Morgan Stanley Underweight $190 → $201
Sep-20-17Downgrade JP Morgan Neutral → Underweight
Apr-26-17Reiterated Stifel Hold $190 → $202
Jan-25-17Reiterated Stifel Hold $187 → $190
Feb-16-19 08:17AM  Is Danaher Stock Still a Good Investment? Motley Fool
Feb-14-19 04:45PM  3M Announces Upcoming Investor Events Business Wire
02:30PM  Industrial ETFs Stay Strong Despite Mixed Earnings Zacks
10:40AM  3M Statement on EPAs PFAS Action Plan Business Wire
09:41AM  Microbial detective firm lands $14 million from 3M, others to track global supply chain from dust to data American City Business Journals
Feb-13-19 10:45AM  Apple, Walmart, IBM CEOs join White House advisory panel Reuters
10:21AM  Stock Market News For Feb 13, 2019 Zacks
Feb-11-19 05:00AM  Dow Underdogs for 2019 MoneyShow
Feb-09-19 09:04AM  The Rise of Online Retail Has Cascading Effects for Corporate America Motley Fool
Feb-07-19 05:48PM  3M Co (MMM) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
12:45PM  The Stock Market Might Not Be Ready for a Stronger Dollar Barrons.com
08:10AM  Should You Invest in the Fidelity MSCI Industrials Index ETF (FIDU)? Zacks
Feb-06-19 07:25PM  3M Gives Back through Celebrity Challenge at AT&T Pebble Beach Pro-Am: Students and Charities Win Business Wire
09:00AM  3M Leadership Announcement Business Wire
Feb-05-19 05:00PM  3M Board Increases Dividend 6 Percent Business Wire
Feb-04-19 07:14PM  Odd trend emerging in the chip stocks CNBC Videos
Feb-01-19 07:47PM  3M Opens 2019 on an Unimpressive Note Motley Fool
04:30PM  3M Completes Acquisition of M*Modal's Technology Business Business Wire
08:27AM  Dow 30 Stock Roundup: MCD, BA, 3M, MSFT, PFE, V Earnings Impress Zacks
Jan-31-19 03:00PM  3M sued by veterans over military-grade earplugs American City Business Journals
11:15AM  3M and Elo Touch Solutions Settle Patent Infringement Action Business Wire
11:00AM  3M and Miraenanotech Complete Patent License Agreement for Metal Mesh Technology Business Wire
Jan-30-19 03:12PM  5 Industrial Stocks to Buy InvestorPlace
01:55PM  3M Trims Its 2019 Earnings Guidance, but Don't Blame China Motley Fool
11:33AM  Strong On-Balance-Volume Lines Point the Way Higher for 3M Shares TheStreet.com
06:36AM  7 Dividend Stocks With a 60-Year Streak of Increasing Their Payouts Motley Fool
04:30AM  Edited Transcript of MMM earnings conference call or presentation 29-Jan-19 2:00pm GMT Thomson Reuters StreetEvents
Jan-29-19 09:52PM  3M (MMM) Q4 2018 Earnings Conference Call Transcript Motley Fool
08:30PM  5 Dividend Kings Built for the Long Term Motley Fool
07:23PM  [$$] 3M Lowers Profit Outlook for 2019 The Wall Street Journal
04:28PM  3M Shares Gain Despite Lower 2019 Guidance After Q4 Earnings TheStreet.com
04:20PM  Dow Closes Modestly Higher Ahead of Apple Earnings TheStreet.com
01:40PM  Apple Earnings Preview & Latest Results from Verizon, 3M, and Pfizer Zacks
01:08PM  3M warns of slowdown in China, trims sales forecast Reuters
12:56PM  [$$] 3M Lowers Profit Outlook for 2019 The Wall Street Journal
11:50AM  3M warns of slowdown in China, trims sales forecast Reuters
11:50AM  Stocks - Wall Street Closes Mixed as Tech Tumbles Investing.com
11:32AM  3M warns of slowdown in China, trims sales forecast Reuters
11:19AM  3M's Results Aren't All That Comforting Bloomberg
11:02AM  Apple To Report Fiscal Q1 Earnings Zacks
11:02AM  Align Earnings, Revenue beat in Q4 Investing.com
10:18AM  3M consumer sales in Asia hurt by cleaner air in China MarketWatch
10:16AM  The Apple (AAPL) of Investors' Eye Zacks
10:01AM  3M (MMM) Beats Q4 Earnings Estimates, Revises '19 View Down Zacks
10:00AM  3M Shakes Off Global Worries as Profit, Sales Exceed Estimates Bloomberg
09:25AM  Dow earnings reporters' stocks would boost Dow's price by 11 points MarketWatch
08:10AM  3M (MMM) Q4 Earnings and Revenues Beat Estimates Zacks
06:50AM  3M: 4Q Earnings Snapshot Associated Press
06:43AM  3M tops profit and sales estimates, tweaks outlook due to acquisition MarketWatch
06:30AM  3M Reports Fourth-Quarter 2018 Results Business Wire
03:18AM  Stocks - Pfizer, Verizon, PG&E Slump in Premarket, Harley Davidson Tumbles Investing.com
12:25AM  Top 5 Things to Know in The Market on Tuesday Investing.com
Jan-28-19 03:10PM  3M Option Bears Emerge Ahead of Earnings Schaeffer's Investment Research
03:04PM  Army Veterans ALERT: Federman & Sherwood Investigates 3M Company Business Wire
09:19AM  MMM, DHR Q4 Earnings on Jan 29: Here are the Key Predictions Zacks
Jan-25-19 09:17AM  Can Weak Organic Sales & Cost Woes Hurt 3M's (MMM) Q4 Earnings? Zacks
Jan-24-19 09:34AM  3M Charts Suggest a Core Long Position Pre-Earnings TheStreet.com
Jan-22-19 03:03PM  5 stocks account for nearly 200-points of Dow's tumble MarketWatch
Jan-18-19 03:12PM  Boeing (BA) Stock Was a Strong Buy Before US-China Trade Positivity Zacks
08:36AM  Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress Zacks
Jan-17-19 09:00AM  3M and Nobel Media Partner to Inspire Lifelong Search for Knowledge at 'The Future of Learning' Nobel Prize Dialogue Event Business Wire
Jan-16-19 11:30AM  Should We Be Delighted With 3M Companys (NYSE:MMM) ROE Of 44%? Simply Wall St.
10:01AM  3M (MMM) & Eckhart Introduce 3M Automated Taping System Zacks
08:21AM  Should You Invest in the Fidelity MSCI Industrials Index ETF (FIDU)? Zacks
08:00AM  Today's Research Reports on Trending Tickers: 3M and Arconic ACCESSWIRE
Jan-15-19 04:37PM  3M & Eckhart Announce Successful Development of the Collaborative Robot-based 3M Automated Taping System Business Wire
03:49PM  3Ms stock leads Dow losers as most bearish analyst gets even more bearish MarketWatch
Jan-14-19 05:50PM  3M (MMM) Stock Moves -0.02%: What You Should Know Zacks
10:15AM  Stock Market News for Jan 14, 2019 Zacks
Jan-11-19 12:32PM  Why DowDuPont Stock Fell Almost 25% in 2018 Motley Fool
09:53AM  3M Announces Upcoming Investor Events Business Wire
Jan-10-19 08:59PM  Why 3M Stock Dropped 19% in 2018 Motley Fool
04:49PM  The Best Stock Funds for Risky Markets Barrons.com
Jan-08-19 07:21AM  200 Million Reasons Why 3M's Latest Buy Is a Smart Move Motley Fool
Jan-07-19 05:50PM  3M (MMM) Stock Sinks As Market Gains: What You Should Know Zacks
12:55PM  The 9 Best Dividend Growth Stocks in the Dow Jones Kiplinger
Jan-06-19 02:22AM  3 Dividend Stocks That Should Pay You the Rest of Your Life Motley Fool
Jan-04-19 11:10AM  Stocks - Wall Street Flies High on Fed Patience, Job Gains Investing.com
09:30AM  CSL vs. MMM: Which Stock Is the Better Value Option? Zacks
05:26AM  3M Rises 3% Investing.com
Jan-03-19 09:58AM  Zacks Earnings Trends Highlights: FedEx, Caterpillar, Honeywell and 3M Zacks
06:32AM  Expect a Quick 2019 Dividend Increase From These 3 Stocks Motley Fool
05:04AM  3M Falls 3% Investing.com
Jan-02-19 06:08PM  Concerns grow over economic slowdown in China CNBC Videos
05:01PM  Previewing the Q4 Earnings Season Zacks
04:56PM  Previewing the Q4 Earnings Season Zacks
Jan-01-19 10:39AM  These Are The 5 Worst Dow Jones Stocks Of 2018 Investor's Business Daily
Dec-28-18 07:46PM  Forget 3M: GE Is a Better-Value Stock Motley Fool
Dec-27-18 11:13AM  Stocks - Market Stages a Serious Late-Day Rally to Close Higher Investing.com
Dec-26-18 05:36PM  3M Rises 3% Investing.com
11:49AM  3M (MMM) Gains From Restructuring Moves, Costs Remain High Zacks
Dec-25-18 08:00AM  3M Stock Had a Rough 2018 Amid Weakness in the Industrial Sector Barrons.com
Dec-21-18 11:34AM  Sale of Franklin tech division to 3M values it at $1B American City Business Journals
09:47AM  The Zacks Analyst Blog Highlights: Disney, U.S. Bancorp, EOG, 3M and Micron Zacks
Dec-20-18 02:08PM  3M Company (NYSE:MMM): Should The Recent Earnings Drop Worry You? Simply Wall St.
10:52AM  Top Stock Reports for Disney, U.S. Bancorp & EOG Resources Zacks
09:01AM  3M (MMM) to Fortify HIS Business on MModal's Buyout Deal Zacks
Dec-19-18 04:06PM  GE Stock: General Electric Files For GE Healthcare IPO; Gets Key Upgrade Investor's Business Daily
12:24PM  3M buys Pittsburgh-based technology business for $1B American City Business Journals
11:55AM  Why I Am Considering Selling 3M GuruFocus.com
3M Company operates as a diversified technology company worldwide. The company's Industrial segment offers tapes; coated, non-woven, and bonded abrasives; adhesives; ceramics; sealants; specialty materials; purification products; closure systems for personal hygiene products; acoustic systems products; automotive components; and abrasion-resistant films, and paint finishing and detailing products. Its Safety and Graphics Business segment provides personal protection products, transportation safety products, commercial graphics systems, commercial cleaning and protection products, floor matting, roofing granules for asphalt shingles, and fall protection products. The company's Health Care segment offers medical and surgical supplies, skin health and infection prevention products, inhalation and transdermal drug delivery systems, dental and orthodontic products, health information systems, and food safety products. Its Electronics and Energy segment provides optical films; packaging and interconnection devices; insulating and splicing solutions; touch screens and touch monitors; renewable energy component solutions; and infrastructure protection products. The company's Consumer segment offers sponges, scouring pads, high-performance cloths, repositionable notes, indexing systems, home improvement and care products, and protective materials; and consumer and office tapes and adhesives. 3M Company also provides cloud-based, conversational artificial intelligence-powered systems. It serves automotive, electronics and automotive electrification, appliance, paper and printing, packaging, food and beverage, construction, medical clinics and hospitals, pharmaceuticals, dental and orthodontic practitioners, health information systems, food manufacturing and testing, consumer and office retail, office business to business, home improvement, drug and pharmacy retail, and other markets. The company was founded in 1902 and is headquartered in St. Paul, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bauman James LExecutive Vice PresidentFeb 11Option Exercise78.7216,0651,264,63740,468Feb 13 02:02 PM
Bauman James LExecutive Vice PresidentFeb 11Sale200.2416,0653,216,80424,403Feb 13 02:02 PM
Keel Paul ASenior Vice PresidentFeb 08Option Exercise78.729,410740,75523,009Feb 11 09:35 AM
Keel Paul ASenior Vice PresidentFeb 08Sale199.149,4101,873,92413,599Feb 11 09:35 AM
Lindekugel Jon TSenior Vice PresidentFeb 07Option Exercise89.475,940531,45216,415Feb 11 09:25 AM
Bushman Julie LExecutive Vice PresidentFeb 07Option Exercise78.7213,1721,036,90046,701Feb 11 09:11 AM
Vale Michael G.Executive Vice PresidentFeb 07Option Exercise78.728,906701,08052,225Feb 11 09:29 AM
Gangestad Nicholas CSr. VP & CFOFeb 07Option Exercise78.721,681132,32832,372Feb 11 09:53 AM
Vrohidis IppocratisVice President & CAOFeb 07Option Exercise114.437,547863,6364,658Feb 11 10:26 AM
Vrohidis IppocratisVice President & CAOFeb 07Sale199.518,1531,626,635786Feb 11 10:26 AM
Gangestad Nicholas CSr. VP & CFOFeb 07Sale201.344,681942,45030,691Feb 11 09:53 AM
Vale Michael G.Executive Vice PresidentFeb 07Sale199.298,9061,774,91943,319Feb 11 09:29 AM
Lindekugel Jon TSenior Vice PresidentFeb 07Sale199.635,9401,185,79110,475Feb 11 09:25 AM
Bushman Julie LExecutive Vice PresidentFeb 07Sale199.903,123624,29533,529Feb 11 09:19 AM
Bushman Julie LExecutive Vice PresidentFeb 07Sale199.665,8291,163,80936,652Feb 11 09:15 AM
Bushman Julie LExecutive Vice PresidentFeb 07Sale199.384,220841,39242,481Feb 11 09:11 AM
THULIN INGE GExec ChairmanJan 31Option Exercise78.7213,2901,046,189243,748Feb 01 11:23 AM
THULIN INGE GExec ChairmanJan 31Sale200.0313,2902,658,348230,458Feb 01 11:23 AM
THULIN INGE GExec ChairmanJan 30Option Exercise78.7211,793928,345242,251Feb 01 10:13 AM
THULIN INGE GExec ChairmanJan 30Sale200.0013,4992,699,862230,458Feb 01 10:13 AM
PAGE GREGORY RDirectorOct 26Buy184.501,000184,5002,000Oct 29 02:48 PM
Lindekugel Jon TSenior Vice PresidentOct 01Option Exercise212.191,250265,2385,909Oct 02 04:47 PM
Hammes Eric D.Senior Vice PresidentSep 10Option Exercise54.111,27268,8285,634Sep 11 03:40 PM
Hammes Eric D.Senior Vice PresidentSep 10Sale216.001,272274,7524,362Sep 11 03:40 PM
Lindekugel Jon TSenior Vice PresidentAug 10Option Exercise78.726,410504,59511,051Aug 13 05:13 PM
Lindekugel Jon TSenior Vice PresidentAug 10Sale203.016,4101,301,2664,641Aug 13 05:13 PM
Ashish Khandpur KExecutive Vice PresidentJun 01Option Exercise199.591,324264,2576,347Jun 05 02:30 PM
McGrath Marlene MarySenior VP - Human ResourcesJun 01Option Exercise199.593,523703,15627,687Jun 05 02:02 PM
Little Frank R Jr.Executive Vice PresidentFeb 23Sale236.853,133742,0517,539Feb 26 04:55 PM
UNH UnitedHealth Group Incorporated daily Stock Chart
UNH [NYSE]
UnitedHealth Group Incorporated
IndexDJIA S&P500 P/E22.23 EPS (ttm)12.19 Insider Own0.40% Shs Outstand963.00M Perf Week3.52%
Market Cap261.10B Forward P/E16.32 EPS next Y16.62 Insider Trans-3.36% Shs Float956.43M Perf Month3.70%
Income11.99B PEG1.41 EPS next Q3.60 Inst Own88.20% Short Float0.66% Perf Quarter0.71%
Sales226.25B P/S1.15 EPS this Y28.30% Inst Trans-0.24% Short Ratio1.55 Perf Half Y4.04%
Book/sh53.68 P/B5.05 EPS next Y13.54% ROA7.80% Target Price306.39 Perf Year18.51%
Cash/sh11.28 P/C24.03 EPS next 5Y15.80% ROE24.30% 52W Range212.49 - 287.94 Perf YTD8.84%
Dividend3.60 P/FCF25.28 EPS past 5Y17.30% ROI15.60% 52W High-5.84% Beta0.84
Dividend %1.33% Quick Ratio- Sales past 5Y13.10% Gross Margin- 52W Low27.59% ATR5.01
Employees300000 Current Ratio- Sales Q/Q12.20% Oper. Margin7.70% RSI (14)59.43 Volatility1.84% 1.73%
OptionableYes Debt/Eq0.71 EPS Q/Q27.20% Profit Margin5.30% Rel Volume0.90 Prev Close265.33
ShortableYes LT Debt/Eq0.67 EarningsJan 15 BMO Payout27.70% Avg Volume4.09M Price271.13
Recom1.60 SMA201.92% SMA504.78% SMA2005.12% Volume3,673,690 Change2.19%
Jan-14-19Initiated Stephens Overweight $287
Sep-10-18Downgrade Citigroup Buy → Neutral
Jun-11-18Initiated SunTrust Buy $300
Mar-08-18Initiated Barclays Overweight $265
Jan-17-18Reiterated Citigroup Buy $235 → $268
Jan-12-18Reiterated Evercore ISI Outperform $235 → $255
Jan-03-18Initiated Goldman Buy $269
Jul-19-17Reiterated Mizuho Buy $200 → $235
Jun-07-17Initiated Morgan Stanley Overweight
Apr-18-17Reiterated Mizuho Buy $178 → $200
Apr-05-17Initiated Deutsche Bank Buy $183
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Upgrade Cantor Fitzgerald Hold → Buy
Nov-30-16Upgrade Mizuho Neutral → Buy $178
Nov-30-16Reiterated RBC Capital Mkts Outperform $168 → $175
Nov-09-16Downgrade Mizuho Buy → Neutral
Oct-19-16Reiterated Mizuho Buy $160 → $169
Jul-22-16Upgrade Argus Hold → Buy
Jul-20-16Reiterated RBC Capital Mkts Outperform $157 → $165
Jul-19-16Reiterated Mizuho Buy $156 → $160
Feb-14-19 05:48PM  These are the most beloved stocks in the Dow CNBC Videos
09:30AM  Why Is UnitedHealth (UNH) Up 0.9% Since Last Earnings Report? Zacks
09:30AM  UnitedHealthcare Vision Plans Again Rank Highest in Customer Satisfaction in J.D. Power Report Business Wire
08:38AM  Here's Why Investing in Molina Healthcare (MOH) Makes Sense Zacks
Feb-13-19 09:19AM  UnitedHealth Stock Is a Buy, but Keep an Eye on the External Risks InvestorPlace
08:30AM  Ex-Mayo Clinic CEO Dr. John Noseworthy joining UnitedHealth's board of directors American City Business Journals
06:50AM  John H. Noseworthy, M.D., Joins UnitedHealth Group Board of Directors Business Wire
Feb-12-19 05:48PM  UnitedHealth Group Inc (UNH) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
01:04PM  Buy UnitedHealth? Sell General Dynamics for Boeing? The traders take your questions CNBC Videos
09:38AM  Stock Market News For Feb 12, 2019 Zacks
Feb-11-19 10:32AM  Dow turns negative in morning trade as declines in Disney, UnitedHealth stocks weigh MarketWatch
09:18AM  Top Ranked Value Stocks to Buy for February 11th Zacks
Feb-08-19 01:38PM  Dow Jones Today: UnitedHealth, Intel Lead Blue Chips Lower; Merck Sets Up Investor's Business Daily
11:04AM  The World's Top 10 Health Care Companies (UNH, MDT) Investopedia
09:53AM  UnitedHealth Falls 3% Investing.com
Feb-07-19 11:17AM  UnitedHealthcare Confronts the Opioid Epidemic by Introducing Oral Health Programs and Policies Business Wire
08:11AM  Top Ranked Value Stocks to Buy for February 7th Zacks
Feb-06-19 09:21AM  Top Ranked Value Stocks to Buy for February 6th Zacks
07:55AM  UnitedHealth Group Incorporated (NYSE:UNH): The Best Of Both Worlds Simply Wall St.
Feb-05-19 04:40PM  David Carlson Buys UnitedHealth, Mastercard GuruFocus.com
01:19PM  IBD 50 Stocks To Watch: Blue Chip UnitedHealth Shapes Bullish Base Investor's Business Daily
10:59AM  Top Ranked Growth Stocks to Buy for February 5th Zacks
09:15AM  BioTelemetry (BEAT) Hits 52-Week High, Can the Run Continue? Zacks
08:53AM  UnitedHealth, MercadoLibre, Alphabet and Gilead highlighted as Zacks Bull and Bear of the Day Zacks
08:20AM  The Zacks Analyst Blog Highlights: UnitedHealth, Banco Bradesco, Itau, Banco Santander and Rio Zacks
08:16AM  The Zacks Analyst Blog Highlights: Microsoft, Facebook, UnitedHealth, Mastercard and ExxonMobil Zacks
08:03AM  Dow Records Sixth Straight Weekly Gain: 4 Top Picks Zacks
06:55AM  Bull of the Day: UnitedHealth Group (UNH) Zacks
Feb-04-19 03:21PM  UnitedHealthcare to Serve People in North Carolina State Medicaid Program Business Wire
02:55PM  Top Stock Reports for Microsoft, Facebook & UnitedHealth Zacks
09:30AM  Has UnitedHealth Group (UNH) Outpaced Other Medical Stocks This Year? Zacks
09:21AM  New Strong Buy Stocks for February 4th Zacks
Feb-02-19 10:07AM  Lightning Strikes the Least Popular Middlemen in Healthcare Motley Fool
Feb-01-19 03:59PM  Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva Reuters
02:09PM  Cigna's (CI) Q4 Earnings Miss, Revenues Surpass Estimates Zacks
11:36AM  Cigna sinks on investor worries about Trump drug rebate rule change CNBC
11:00AM  Prescription manager stocks dip after rebate change pitched Associated Press
07:32AM  Dow Jones Futures: Amazon.com, CVS Lead Key Movers As Jobs Report Looms Investor's Business Daily
Jan-31-19 06:37PM  U.S. government proposes rule overhauling drug industry rebate system Reuters
07:57AM  Stocks making the biggest moves premarket: DowDuPont, GE, Tesla, Facebook & more CNBC
01:14AM  PRESS DIGEST- Wall Street Journal - Jan 31 Reuters
Jan-30-19 08:52PM  [$$] New Details on Amazon, Berkshire Hathaway, JPMorgan Health Venture Emerge in Court Battle The Wall Street Journal
08:45PM  New Details on Amazon, Berkshire Hathaway, JPMorgan Health Venture Emerge in Court Battle The Wall Street Journal
03:56PM  In Nashville, Wall Street pros predict health care's future American City Business Journals
10:41AM  Dow ETF Could Face Near-Term Pressure ETF Trends
05:00AM  Two Tactical Trades- Best-of-Breed Healthcare Ideas MoneyShow
Jan-29-19 09:30AM  UnitedHealthcare Donates $50,000 to North Carolina Nonprofits to Support Ongoing Needs for People Recovering from Hurricane Florence Business Wire
Jan-28-19 10:20AM  UnitedHealth, Morgan Stanley Are Among Stocks With Crazy Insider Activity TheStreet.com
Jan-25-19 10:58AM  Top Ranked Value Stocks to Buy for January 25th Zacks
10:20AM  Hot Stocks Boost USAA Aggressive Growth Investor's Business Daily
Jan-24-19 10:11AM  Top Ranked Growth Stocks to Buy for January 24th Zacks
08:15AM  UnitedHealth sues IT exec who left for Amazon-Berkshire-Chase health supergroup American City Business Journals
Jan-23-19 06:20PM  UnitedHealth sues ex-executive for taking trade secrets to Amazon joint health venture CNBC
10:41AM  Top Ranked Value Stocks to Buy for January 23rd Zacks
08:53AM  Zacks.com featured expert Kevin Matras highlights: Boeing, HCA Healthcare, Lithia Motors, O'Reilly Automotive and UnitedHealth Zacks
07:21AM  Should You Investigate UnitedHealth Group Incorporated (NYSE:UNH) At US$266? Simply Wall St.
Jan-22-19 10:38PM  Miami Valley Hospital, OH -- Moody's downgrades Premier Health Partners (OH) and Miami Valley Hospital (OH) to Baa1 from A3; outlook remains negative Moody's
05:20PM  FORTUNE 2019 Survey Ranks UnitedHealth Group "World's Most Admired Company" in Insurance and Managed Care Business Wire
08:51AM  Tap These 5 Stocks With Impressive Interest Coverage Ratio Zacks
08:19AM  Why You Should Hold Mednax (MD) Stock in Your Portfolio Zacks
Jan-21-19 09:30AM  Top Ranked Value Stocks to Buy for January 21st Zacks
Jan-18-19 03:29PM  UnitedHealthcare, Techstars to launch startup accelerator later this year American City Business Journals
08:36AM  Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress Zacks
04:25AM  Edited Transcript of UNH earnings conference call or presentation 15-Jan-19 1:45pm GMT Thomson Reuters StreetEvents
Jan-17-19 03:24PM  UnitedHealth Is a Steady Investment for the Patient Investor InvestorPlace
09:30AM  Is UnitedHealth Group (UNH) Outperforming Other Medical Stocks This Year? Zacks
08:04AM  Top Ranked Value Stocks to Buy for January 17th Zacks
07:35AM  Analysis: Positioning to Benefit within Motorola Solutions, FibroGen, UnitedHealth Group, Newell Brands, Vuzix, and Choice Hotels International Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jan-16-19 02:14PM  UnitedHealth Gains on Strong 4Q Results, 2019 Looks Favorable Zacks
01:42PM  BofA, Raymond James Bullish On UnitedHealth's Growth Prospects After Q4 Beat Benzinga
11:20AM  UnitedHealth Pops on Solid Q4: Healthcare ETFs to Buy Zacks
09:28AM  Stock Market News For Jan 16, 2019 Zacks
Jan-15-19 09:47PM  UnitedHealth Group (UNH) Q4 2018 Earnings Conference Call Transcript Motley Fool
09:13PM  UnitedHealth Group Beats Q4 Earnings as Optum Revenue Tops $100 Billion in 2018 TheStreet.com
08:26PM  [$$] UnitedHealth Sales Rise Across Segments The Wall Street Journal
05:37PM  Netflix, UnitedHealth and Edwards climb; Wells Fargo dips Associated Press
05:02PM  What Happened in the Stock Market Today Motley Fool
04:37PM  US STOCKS-Netflix, China boost Wall St as investors shrug off Brexit vote Reuters
04:06PM  UnitedHealth Earnings Top Estimates Investor's Business Daily
04:06PM  Dow Gains Triple Digits, Nasdaq Surges After Netflix Price Hike TheStreet.com
03:22PM  US STOCKS-Wall Street rises as Netflix boosts tech, internet stocks Reuters
03:11PM  UnitedHealth Stock Is Higher After Earnings Beat Barrons.com
02:54PM  [$$] UnitedHealth Sales Rise Across Segments The Wall Street Journal
01:40PM  US STOCKS-Netflix, tech rally lift Wall Street as investors shrug off weak bank results Reuters
01:26PM  The Earnings Story So Far & What To Watch During Q4 Report Season Zacks
12:48PM  UnitedHealth profit beats expectations, shares rise Reuters
11:47AM  UnitedHealth profit beats expectations, shares rise Reuters
10:47AM  I'm Focused on Stalking an Entry Point for an Index Short TheStreet.com
10:34AM  Economic Data Deluge Zacks
10:29AM  UnitedHealth shares climb after 4Q earnings beat Associated Press
10:22AM  PPI Joins Q4 Reports for JPM, WFC & More; Big Day for Data Zacks
10:15AM  Tech Stocks Advance With These 2 Dow Jones Stocks Mixed On Earnings Investor's Business Daily
10:00AM  UnitedHealth says Medicaid cost issues are short-term Reuters
09:42AM  Stocks Climb Ahead Of Brexit: Dow Jones Lags, Netflix Spikes Investor's Business Daily
09:34AM  UnitedHealth Finishes 2018 on a Healthy Note Motley Fool
09:22AM  UnitedHealth (UNH) Beats on 4Q Earnings, Keeps 2019 Guidance Zacks
09:17AM  UnitedHealth says performing better than first-quarter consensus estimate suggests Reuters
08:27AM  UnitedHealth earnings fall, but still beat outlook American City Business Journals
08:10AM  UnitedHealth Group (UNH) Surpasses Q4 Earnings and Revenue Estimates Zacks
07:55AM  Stocks making the biggest moves premarket: JPM, UNH, DAL, AAPL, TLRY & more CNBC
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery and specialty pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BURKE RICHARD TDirectorJan 23Sale268.0011,5003,082,000182,372Jan 24 04:26 PM
BALLARD WILLIAM C JRDirectorJan 22Option Exercise20.685,000103,40077,702Jan 23 04:26 PM
BALLARD WILLIAM C JRDirectorJan 22Sale266.615,0001,333,03572,702Jan 23 04:26 PM
BURKE RICHARD TDirectorJan 17Sale260.5515,0003,908,259193,872Jan 18 04:26 PM
BURKE RICHARD TDirectorJan 01Option Exercise27.595,000137,950208,661Jan 03 04:01 PM
HEMSLEY STEPHEN JExecutive Chair of the BoardNov 30Option Exercise29.74169,6835,046,3722,136,409Dec 04 05:21 PM
WILENSKY GAIL RDirectorNov 28Option Exercise27.915,880164,12164,444Nov 29 04:51 PM
BURKE RICHARD TDirectorNov 28Sale281.726,0901,715,6861,711,584Nov 29 04:50 PM
WILENSKY GAIL RDirectorNov 28Sale279.775,8801,645,06659,444Nov 29 04:51 PM
Shine Kenneth IrwinDirectorNov 09Sale274.8316344,79629,153Nov 13 04:37 PM
BURKE RICHARD TDirectorOct 26Option Exercise22.432,32052,0381,717,674Oct 30 04:49 PM
BURKE RICHARD TDirectorSep 26Option Exercise25.085,000125,4001,715,191Sep 27 04:39 PM
HOOPER MICHELE JDirectorSep 13Option Exercise25.165,000125,80037,865Sep 17 04:40 PM
HOOPER MICHELE JDirectorSep 13Sale264.865,0001,324,30932,865Sep 17 04:40 PM
BURKE RICHARD TDirectorSep 13Sale264.9010,0002,649,0271,710,112Sep 17 04:39 PM
Nelson Steven HEVP & CEO, UnitedHealthcareSep 13Sale265.008,1422,157,63022,496Sep 17 04:37 PM
WILENSKY GAIL RDirectorSep 12Option Exercise24.745,740141,99864,947Sep 13 04:34 PM
WILENSKY GAIL RDirectorSep 12Sale263.455,7401,512,18659,207Sep 13 04:34 PM
BURKE RICHARD TDirectorSep 12Sale263.4120,0005,268,1641,720,112Sep 13 04:33 PM
Nelson Steven HEVP & CEO, UnitedHealthcareSep 07Option Exercise111.6538,2494,270,45756,671Sep 10 04:32 PM
Nelson Steven HEVP & CEO, UnitedHealthcareSep 07Sale270.6526,0337,045,80030,638Sep 10 04:32 PM
WILSON D ELLENEVP Human CapitalAug 24Option Exercise57.3818,0001,032,84066,402Aug 28 04:46 PM
WILSON D ELLENEVP Human CapitalAug 24Sale264.2915,3934,068,27651,009Aug 28 04:46 PM
BALLARD WILLIAM C JRDirectorAug 08Option Exercise26.3410,000263,35077,172Aug 09 04:33 PM
BALLARD WILLIAM C JRDirectorAug 08Sale258.8310,0002,588,31072,172Aug 09 04:33 PM
BURKE RICHARD TDirectorAug 01Sale254.7915,0003,821,9131,740,112Aug 03 04:36 PM
WILENSKY GAIL RDirectorJul 18Option Exercise27.0289024,04862,297Jul 19 05:37 PM
WILENSKY GAIL RDirectorJul 18Sale252.103,090779,00159,207Jul 19 05:37 PM
Shine Kenneth IrwinDirectorJul 18Sale255.7217745,26229,053Jul 19 05:36 PM
BURKE RICHARD TDirectorJul 17Option Exercise27.021,78048,0961,755,112Jul 19 05:36 PM
BURKE RICHARD TDirectorJun 29Option Exercise25.635,000128,1501,753,155Jul 02 04:41 PM
WILENSKY GAIL RDirectorJun 29Option Exercise25.635,000128,15061,753Jul 02 04:42 PM
RENFRO LARRY CVice Chmn, UHG and CEO, OptumJun 15Sale254.5519,6525,002,436153,679Jun 19 04:33 PM
BURKE RICHARD TDirectorMay 30Option Exercise33.941,54052,2681,748,073May 31 04:40 PM
BURKE RICHARD TDirectorMay 21Sale248.8215,0003,732,2611,746,533May 23 07:46 PM
BURKE RICHARD TDirectorApr 23Sale234.2015,0003,513,0271,761,533Apr 25 05:36 PM
Shine Kenneth IrwinDirectorApr 19Sale237.4220247,95928,948Apr 20 04:50 PM
BURKE RICHARD TDirectorMar 29Option Exercise36.255,000181,2501,776,331Mar 30 04:17 PM
BURKE RICHARD TDirectorMar 19Sale224.3610,0002,243,6101,771,257Mar 21 04:22 PM
Nelson Steven HEVP & CEO, UnitedHealthcareMar 15Sale230.2214,2333,276,63118,219Mar 19 05:12 PM
RENFRO LARRY CVice Chmn, UHG and CEO, OptumMar 15Sale228.9422,1845,078,805173,229Mar 19 05:11 PM
BURKE RICHARD TDirectorMar 01Sale229.0040091,6001,781,257Mar 02 05:32 PM
BURKE RICHARD TDirectorFeb 28Sale229.9010,0002,299,0161,781,657Mar 02 05:32 PM
NKE NIKE, Inc. daily Stock Chart
NKE [NYSE]
NIKE, Inc.
IndexDJIA S&P500 P/E33.22 EPS (ttm)2.57 Insider Own1.10% Shs Outstand1.56B Perf Week3.67%
Market Cap133.27B Forward P/E27.18 EPS next Y3.14 Insider Trans-4.72% Shs Float1.24B Perf Month9.91%
Income4.19B PEG2.34 EPS next Q0.63 Inst Own84.60% Short Float0.71% Perf Quarter13.54%
Sales38.10B P/S3.50 EPS this Y-4.60% Inst Trans0.89% Short Ratio1.18 Perf Half Y7.30%
Book/sh5.52 P/B15.47 EPS next Y18.26% ROA9.60% Target Price87.33 Perf Year25.63%
Cash/sh2.59 P/C32.98 EPS next 5Y14.18% ROE23.10% 52W Range63.21 - 86.04 Perf YTD15.16%
Dividend0.88 P/FCF38.79 EPS past 5Y12.30% ROI30.00% 52W High-0.77% Beta0.67
Dividend %1.03% Quick Ratio1.40 Sales past 5Y7.50% Gross Margin44.10% 52W Low35.07% ATR1.24
Employees73100 Current Ratio2.10 Sales Q/Q9.60% Oper. Margin12.40% RSI (14)73.53 Volatility1.22% 1.37%
OptionableYes Debt/Eq0.40 EPS Q/Q13.20% Profit Margin5.70% Rel Volume0.81 Prev Close84.68
ShortableYes LT Debt/Eq0.40 EarningsMar 21 AMC Payout58.80% Avg Volume7.47M Price85.38
Recom2.10 SMA204.26% SMA5010.79% SMA20011.30% Volume6,111,250 Change0.83%
Feb-08-19Reiterated Oppenheimer Outperform $90 → $100
Jan-10-19Upgrade Needham Hold → Buy $85
Jan-09-19Upgrade HSBC Securities Hold → Buy
Jan-09-19Downgrade Robert W. Baird Outperform → Neutral
Dec-21-18Upgrade Pivotal Research Group Hold → Buy
Dec-21-18Upgrade JP Morgan Neutral → Overweight
Oct-18-18Upgrade Oppenheimer Perform → Outperform
Oct-03-18Downgrade HSBC Securities Buy → Hold
Sep-21-18Reiterated Pivotal Research Group Hold $78 → $85
Sep-20-18Reiterated Susquehanna Positive $93 → $100
Sep-19-18Reiterated B. Riley FBR Neutral $76 → $84
Sep-18-18Reiterated Telsey Advisory Group Outperform $87 → $92
Sep-11-18Upgrade Canaccord Genuity Hold → Buy $78 → $95
Aug-20-18Upgrade Susquehanna Neutral → Positive
Aug-20-18Upgrade Piper Jaffray Neutral → Overweight
Aug-02-18Initiated Morgan Stanley Overweight
Jun-29-18Reiterated Telsey Advisory Group Outperform $82 → $87
Jun-29-18Reiterated Stifel Buy $87 → $90
Jun-29-18Reiterated Pivotal Research Group Hold $73 → $78
Jun-29-18Reiterated B. Riley FBR, Inc. Neutral $68 → $76
Feb-18-19 09:16AM  Factors Setting the Tone for Wolverine's (WWW) Q4 Earnings Zacks
08:32AM  Factors Likely to Decide Carter's (CRI) Fate in Q4 Earnings Zacks
Feb-15-19 04:41PM  Inside Nike's DIY studio for Snapchat selfie Lenses Engadget
10:58AM  Unboxing Nike's self-lacing Adapt BB sneakers is like opening a smartphone Engadget
08:43AM  Nike Stock Is Set to Surge to $100 Sooner Than You Think InvestorPlace
Feb-14-19 05:36PM  Top technician says we may be nearing market top, but these stocks are going higher CNBC Videos
04:15PM  NIKE, Inc. Declares $0.22 Quarterly Dividend Business Wire
03:47PM  Time to Buy Canada Goose (GOOS) Stock After Post-Earnings Selloff? Zacks
02:27PM  Colorado store forced to close after Nike/Kaepernick boycott Yahoo Finance Video
12:07PM  7 Athletic Stocks That Could Run Higher InvestorPlace
10:07AM  When Will Under Armour Get Its Mojo Back at Home? Motley Fool
07:15AM  Under Armour Earnings Tripped Up by North American Sales Motley Fool
01:58AM  Colorado store closing after boycotting Nike over Kaepernick ad CBS MoneyWatch
Feb-13-19 10:52AM  Why Under Armour Stock Wont Hit $25 InvestorPlace
10:15AM  Under Armour's Sales Fell Off the Pace, but Profits Picked Up Ground Motley Fool
10:00AM  Startup uses Nike-based technology to train the brains of athletes and treat neurological disease American City Business Journals
06:30AM  Mens Yoga Is Yet Another Reason to Buy Nike Stock InvestorPlace
06:00AM  Under Armour Stock Rallies After Earnings But Why? InvestorPlace
Feb-12-19 07:50PM  5 Reasons Skechers Stock Could Keep Soaring Motley Fool
07:35PM  Breaking Down Under Armour (UAA) Stock After Q4 Earnings Zacks
07:19PM  [$$] Under Armour Posts Flat Sales in Holiday Quarter The Wall Street Journal
04:35PM  IBD Stock Of The Day Lululemon Athletica Breaks Out, Joining Nike, Under Armour In Buy Range Investor's Business Daily
04:04PM  Under Armour Earnings Top; Stock Hits Buy Zone Despite Weak Guidance Investor's Business Daily
03:44PM  Under Armour still has trouble in competitive North American market: Expert CNBC Videos
02:40PM  Under Armour shares rise, but analysts remain skeptical after 'mixed' 4Q results American City Business Journals
02:32PM  Its Game Time for Under Armour Stock Bulls InvestorPlace
11:20AM  [$$] Under Armour Posts Flat Sales in Holiday Quarter The Wall Street Journal
10:16AM  After GoPros Surprise Profit, Should Investors Buy GoPro Stock? InvestorPlace
07:58AM  Will Omnichannel Play Key Role in Walmart (WMT) Q4 Earnings? Zacks
01:59AM  Under Armour Shares Jump After Upbeat Q4 Earnings Investing.com
Feb-11-19 07:04PM  Earnings reveal 'brutal truths' about US-China trade CNBC Videos
07:01PM  Jim Cramer: A Cheat Sheet on China Trade Talks TheStreet.com
06:50PM  Cramer: This earnings period revealed 'brutal truths' about US-China trade CNBC Videos
06:20PM  We are partnering with one of the "kingmakers" in the industry, says GOAT CEO CNBC Videos
06:11PM  Cramer: This earnings period revealed 'brutal truths' about US-China trade CNBC
05:45PM  Nike (NKE) Outpaces Stock Market Gains: What You Should Know Zacks
05:09PM  Earnings Growth Deceleration Details Zacks
04:38PM  Nike Stock Could Break Out and Hit $100 TheStreet.com
04:27PM  Stocks Today: Nike Leads Dow Jones; Insperity Breaks Out On Earnings Investor's Business Daily
04:08PM  Future is now: Nike's next self-lacing shoe hitting shelves Associated Press
03:44PM  5 Top Stock Trades for Tuesday: ATVI, GE, UAA, ROKU, SHOP InvestorPlace
01:24PM  NBA Fashion: All-Stars break out specialty shoes for weekend Associated Press
01:00PM  Some of the Nike Indicators Are Giving Me Pause TheStreet.com
12:11PM  NBA Fashion: All-Stars break out specialty shoes for weekend Associated Press
10:47AM  Under Armour, Activision, Nike, Groupon and Cisco are part of Zacks Earnings Preview Zacks
09:30AM  DECK vs. NKE: Which Stock Is the Better Value Option? Zacks
08:45AM  Nike, Lululemon Lead 5 Hot Stocks That Should Be On Your Radar Now Investor's Business Daily
Feb-08-19 04:46PM  Nike's 'Tanjun' Was The Bestselling Shoe Of 2018; Mid-Market Footwear Dominates Top 10 Benzinga
04:10PM  Should You Buy Under Armour (UAA) Stock Ahead of Q4 Earnings? Zacks
11:45AM  Skechers Stock Is Surging, but Nike Isnt an Also-Ran Barrons.com
10:11AM  Stock Market Falls For Third Day; Two Top Growth Stocks Break Out Investor's Business Daily
Feb-07-19 02:33PM  Why Nike Stock Gained 10% in January Motley Fool
07:00AM  Millennials Love These 5 Brands the Most Motley Fool
Feb-06-19 06:15PM  Nike Inc (NKE) CHAIRMAN, PRESIDENT & CEO Mark G Parker Sold $12.3 million of Shares GuruFocus.com
01:01PM  Nike debuts 'Lawn Party' Kit with grass-covered sneakers Yahoo Finance Video
12:33PM  Nike turns to familiar company to go green in Europe American City Business Journals
09:06AM  Check Out Skechers' (SKX) Probability to Beat in Q4 Earnings Zacks
05:00AM  [$$] Nike signs its first clean energy deal in Europe with Iberdrola Financial Times
Feb-05-19 08:58PM  Lunar New Year allows US companies to find prosperity too Associated Press
05:50PM  Nike (NKE) Outpaces Stock Market Gains: What You Should Know Zacks
03:55PM  Former Nike, Under Armour VP to help lead Austin's Outdoor Voices American City Business Journals
Feb-04-19 02:25PM  Dow Jones Stocks To Buy And Watch In February 2019 Investor's Business Daily
10:28AM  Columbia Sportswear (COLM) Q4 Earnings: Will Cost Woes Linger? Zacks
09:08AM  Good News Is Just Around the Corner for SKX Stock InvestorPlace
07:08AM  The Morning After: Nike turns its SNKRS app into a pop-up Engadget
Feb-03-19 11:00AM  Nike turns its SNKRS app into a pop-up shop for sneakerheads Engadget
Feb-02-19 08:44AM  Cowen: Speed-To-Market Initiatives Are Emerging Catalysts For Nike, Adidas, While Kohl's Leads In Private Label Benzinga
Feb-01-19 06:00PM  Should lululemon athletica Worry About Nike's New Yoga Collection? Motley Fool
08:35AM  Flex (FLEX) Q3 Earnings & Revenues Beat Estimates, Shares Up Zacks
Jan-31-19 04:26PM  The Adidas Yeezy Line Expansion Is Working...For Now Benzinga
10:49AM  Leggett (LEG) to Post Q4 Earnings: What's in the Offing? Zacks
03:27AM  Puma is releasing self-lacing smart shoes to take on Nike CNBC
Jan-30-19 10:21PM  Flex Ltd (FLEX) Q3 2019 Earnings Conference Call Transcript Motley Fool
08:45PM  Puma wants to let you try its new Fi self-lacing shoes Engadget
05:50PM  Nike (NKE) Gains But Lags Market: What You Should Know Zacks
11:48AM  'Choose wisely': Inside Flight Club New York, a sneakerhead's heaven Yahoo Finance
11:01AM  Contactless payments are generating more transactions for credit card companies Yahoo Finance Video
08:58AM  Kohl's Teams With Weight Watchers to Boost Health Offerings Zacks
Jan-29-19 03:39PM  The 5 Best Dow Jones Stocks to Buy Now InvestorPlace
03:36PM  How to Tap Into Massive Gains By Pairing Lululemon and Nike Stock InvestorPlace
01:33PM  Heres Another Reason to Buy Nike Stock and Sell Under Armour Stock InvestorPlace
09:03AM  Another jab at Amazon: Walmart is bringing Fanatics to its website to sell NFL jerseys, Nike merchandise and more CNBC
06:45AM  Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar? Zacks
Jan-28-19 01:32PM  Nike Continues to Expand with MLB Deal & The Streaming TV War Heats Up Zacks
10:03AM  Five Things for Monday, including Crater Lake's return and measles in Multnomah County American City Business Journals
09:49AM  Nike Stock Is No Longer Head and Shoulders Above Adidas Stock InvestorPlace
Jan-26-19 01:45PM  Nike Is Safe, Under Armour Is Out as MLB's Jersey Supplier TheStreet.com
Jan-25-19 04:59PM  Swoosh up front: Nike to replace Under Armour for MLB Associated Press
03:33PM  Talking Stocks With a Winning Fund Manager Barrons.com
03:10PM  Nike signs 10-year deal with Major League Baseball American City Business Journals
02:14PM  As Nike Rebounds, So Does Foot Locker, Says Bullish Jefferies Benzinga
12:33PM  Why a Healthy Nike Could Keep Foot Locker Stock Rising Barrons.com
09:30AM  3 Reasons Why Its Time to Buy Baidu Stock on Weakness InvestorPlace
Jan-24-19 03:37PM  Morgan Stanley: Adidas' Pain Is Nike's Gain Benzinga
02:57PM  NIKE, Inc. (NYSE:NKE) Is Employing Capital Very Effectively Simply Wall St.
01:09PM  5 Highest-Paid Soccer Players Investopedia
11:25AM  It Looks Like the Worst Is over, and JD Stock Could Rally Big InvestorPlace
10:07AM  Should You Buy Nike Stock? 3 Pros, 3 Cons InvestorPlace
Jan-23-19 05:07PM  Calceus Acquisition, Inc. -- Moody's upgrades Cole Haan's CFR to B2; assigns B2 to proposed First Lien Term Loan Moody's
01:30PM  Could eBay Stock Actually Double? InvestorPlace
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, and accessories worldwide. The company offers NIKE brand products in six categories: running, NIKE basketball, the Jordan brand, football, training, and sportswear. It also markets products designed for kids, as well as for other athletic and recreational uses, such as American football, baseball, cricket, lacrosse, skateboarding, tennis, volleyball, wrestling, walking, and outdoor activities; and apparel with licensed college and professional team and league logos, as well as sells sports apparel. In addition, the company sells a line of performance equipment and accessories, including bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment under the NIKE brand for sports activities; various plastic products to other manufacturers; athletic and casual footwear, apparel, and accessories under the Jumpman trademark; casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks; and action sports and youth lifestyle apparel and accessories under the Hurley trademark. Further, it licenses agreements that permit unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. NIKE, Inc. sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. The company was formerly known as Blue Ribbon Sports, Inc. and changed its name to NIKE, Inc. in 1971. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PARKER MARK GCHAIRMAN, PRESIDENT & CEOFeb 05Option Exercise13.11147,9001,938,9691,685,763Feb 06 04:31 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOFeb 05Sale82.00147,90012,127,8001,537,863Feb 06 04:31 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOFeb 04Option Exercise13.112,10027,5311,539,963Feb 06 04:31 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOFeb 04Sale82.002,100172,2001,537,863Feb 06 04:31 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOJan 18Option Exercise13.11150,0001,966,5001,687,863Jan 22 04:26 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOJan 18Sale80.00150,00012,000,0001,537,863Jan 22 04:26 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOJan 16Option Exercise13.11150,0001,966,5001,687,863Jan 17 04:25 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOJan 16Sale78.00150,00011,700,0001,537,863Jan 17 04:25 PM
Slusher John FEVP: GBL SPORTS MKTGJan 02Option Exercise22.93200,0004,585,000284,805Jan 04 04:47 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOJan 02Option Exercise13.11150,0001,966,5001,687,863Jan 04 04:48 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOJan 02Sale73.68150,00011,051,6251,537,863Jan 04 04:48 PM
Slusher John FEVP: GBL SPORTS MKTGJan 02Sale74.05200,00014,809,010184,805Jan 04 04:47 PM
RODGERS JOHNATHAN ADirectorSep 19Option Exercise15.7916,000252,64026,963Sep 20 04:53 PM
RODGERS JOHNATHAN ADirectorSep 19Sale85.0516,0001,360,86712,763Sep 20 04:53 PM
Matheson Monique S.EVP: HRSep 18Option Exercise22.9317,000389,725104,737Sep 20 04:51 PM
Matheson Monique S.EVP: HRSep 18Sale85.0017,0001,445,00087,737Sep 20 04:51 PM
Matheson Monique S.EVP: HRSep 11Option Exercise22.9317,000389,725104,737Sep 12 05:15 PM
Matheson Monique S.EVP: HRSep 11Sale83.1517,0001,413,51987,737Sep 12 05:15 PM
Matheson Monique S.EVP: HRJul 30Option Exercise17.2410,000172,40086,774Jul 31 05:00 PM
Matheson Monique S.EVP: HRJul 30Sale76.0710,000760,74676,774Jul 31 05:00 PM
Hill ElliottPRES:CONSUMER & MKTPLCJul 27Sale78.175,741448,774101,121Jul 30 06:45 PM
Campion AndrewEVP: CFOJul 24Sale76.852,907223,403118,809Jul 25 05:40 PM
Campion AndrewEVP: CFOJul 19Sale75.971,904144,647124,450Jul 19 08:21 PM
Campion AndrewEVP: CFOJul 18Sale77.432,226172,359126,354Jul 19 08:21 PM
LECHLEITER JOHN CDirectorJul 10Option Exercise14.3336,000515,90064,073Jul 11 07:18 PM
Krane Hilary KEVP, CAO and General CounselJul 05Sale76.5140,0003,060,552149,956Jul 06 04:15 PM
SPRUNK ERIC DCHIEF OPERATING OFFICERJun 29Option Exercise31.68150,0004,751,250241,959Jul 02 05:26 PM
Campion AndrewEVP: CFOJun 29Option Exercise22.93103,0002,361,275235,457Jul 02 05:25 PM
Campion AndrewEVP: CFOJun 29Sale80.01103,0008,240,670132,457Jul 02 05:25 PM
SPRUNK ERIC DCHIEF OPERATING OFFICERJun 29Sale79.07150,00011,860,000141,959Jul 02 05:26 PM
Matheson Monique S.EVP: Global HRJun 07Option Exercise22.9317,000389,72595,845Jun 11 05:32 PM
Matheson Monique S.EVP: Global HRJun 07Sale75.0017,0001,275,00078,845Jun 11 05:32 PM
SPRUNK ERIC DCHIEF OPERATING OFFICERJun 05Option Exercise23.2745,0001,047,150186,959Jun 06 04:34 PM
SPRUNK ERIC DCHIEF OPERATING OFFICERJun 05Sale74.0145,0003,330,401141,959Jun 06 04:34 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOJun 04Option Exercise14.55135,0001,964,2501,637,736Jun 06 04:34 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOJun 04Sale73.03135,0009,858,6861,502,736Jun 06 04:34 PM
SPRUNK ERIC DCHIEF OPERATING OFFICERMay 22Option Exercise23.2745,0001,047,150186,959May 23 04:45 PM
SPRUNK ERIC DCHIEF OPERATING OFFICERMay 22Sale72.0045,0003,240,000141,959May 23 04:45 PM
SPRUNK ERIC DCHIEF OPERATING OFFICERMay 16Option Exercise23.2750,0001,163,500191,959May 17 06:11 PM
SPRUNK ERIC DCHIEF OPERATING OFFICERMay 16Sale70.0050,0003,500,010141,959May 17 06:11 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOFeb 27Option Exercise14.55135,0001,964,2501,637,736Feb 28 04:39 PM
PARKER MARK GCHAIRMAN, PRESIDENT & CEOFeb 27Sale70.00135,0009,450,0001,502,736Feb 28 04:39 PM
MDT Medtronic plc daily Stock Chart
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E26.72 EPS (ttm)3.45 Insider Own0.10% Shs Outstand1.35B Perf Week3.66%
Market Cap124.49B Forward P/E16.94 EPS next Y5.45 Insider Trans-15.86% Shs Float1.34B Perf Month6.07%
Income4.70B PEG3.24 EPS next Q1.24 Inst Own85.10% Short Float0.64% Perf Quarter0.22%
Sales30.38B P/S4.10 EPS this Y40.40% Inst Trans0.71% Short Ratio1.39 Perf Half Y1.41%
Book/sh36.77 P/B2.51 EPS next Y6.30% ROA- Target Price102.10 Perf Year12.72%
Cash/sh7.51 P/C12.29 EPS next 5Y8.24% ROE- 52W Range76.41 - 100.15 Perf YTD1.44%
Dividend2.00 P/FCF- EPS past 5Y3.80% ROI8.50% 52W High-7.87% Beta0.83
Dividend %2.17% Quick Ratio2.10 Sales past 5Y12.50% Gross Margin70.50% 52W Low20.76% ATR1.33
Employees86000 Current Ratio2.60 Sales Q/Q6.10% Oper. Margin- RSI (14)67.58 Volatility1.03% 1.47%
OptionableYes Debt/Eq0.50 EPS Q/Q-42.70% Profit Margin- Rel Volume0.90 Prev Close91.23
ShortableYes LT Debt/Eq0.48 EarningsFeb 19 BMO Payout- Avg Volume6.21M Price92.27
Recom2.20 SMA204.55% SMA503.36% SMA2002.00% Volume5,622,496 Change1.14%
Feb-04-19Reiterated Needham Strong Buy $120 → $117
Jan-03-19Initiated Deutsche Bank Buy $99
Jan-02-19Downgrade Citigroup Buy → Neutral
Dec-19-18Upgrade JP Morgan Neutral → Overweight
Nov-28-18Initiated UBS Buy
Oct-16-18Initiated Barclays Overweight $113
Aug-27-18Reiterated Argus Buy $95 → $108
Aug-22-18Reiterated Stifel Hold $87 → $96
Aug-13-18Upgrade Needham Buy → Strong Buy $103 → $119
Jun-27-18Initiated Bernstein Mkt Perform $88
Jun-06-18Resumed William Blair Mkt Perform
Jun-06-18Reiterated Needham Buy $97 → $103
May-31-18Initiated Raymond James Outperform $96
Apr-27-18Resumed Piper Jaffray Overweight $90
Feb-22-18Reiterated Citigroup Buy $100 → $93
Jan-03-18Initiated Evercore ISI Outperform $92.50
Jan-02-18Upgrade BofA/Merrill Neutral → Buy
Dec-12-17Upgrade Argus Hold → Buy
Nov-22-17Reiterated Stifel Hold $83 → $85
Oct-10-17Reiterated Needham Buy $95 → $94
Feb-18-19 04:00PM  Medtronic Expected to Earn $1.24 a Share TheStreet.com
Feb-17-19 06:46PM  Medtronic Announces Preliminary PRODIGY Results: a Global Study to Identify Patients at High Risk for Opioid-Induced Respiratory Compromise GlobeNewswire
12:46AM  Economic Calendar - Top 5 Things to Watch This Week Investing.com
Feb-15-19 06:47PM  Cramer's game plan: Investors shouldn't underestimate the importance of a trade deal with China CNBC
Feb-14-19 08:07AM  Here's What Will Give Shape to Medtronic's (MDT) Q3 Earnings Zacks
08:01AM  Medtronic and Medical University of South Carolina Partner to Improve Patient Outcomes GlobeNewswire
Feb-13-19 05:50PM  Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know Zacks
11:17AM  10 Buy-and-Hold Stocks to Own Forever InvestorPlace
07:30AM  Medtronic Heart Pump is the First to Receive Health Canada Licence for Less-Invasive Implant Procedure CNW Group
Feb-12-19 10:30AM  Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Feb-11-19 09:58AM  Smith & Nephew Drops on Report of Deal Talks With NuVasive Bloomberg
08:30AM  New Research Coverage Highlights Medtronic, Hewlett Packard Enterprise, World Wrestling Entertainment, Neogen, Holly Energy Partners, and Drive Shack Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Feb-08-19 11:04AM  The World's Top 10 Health Care Companies (UNH, MDT) Investopedia
11:01AM  Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2019 GlobeNewswire
Feb-07-19 11:43AM  4 Health-Care Stocks With Yields Above 2% Barrons.com
07:02AM  Medtronic Receives FDA Approval on Expanded Indication for Pipeline Flex Embolization Device GlobeNewswire
Feb-04-19 08:46AM  Do Medtronic plcs (NYSE:MDT) Returns On Capital Employed Make The Cut? Simply Wall St.
Jan-30-19 03:21PM  5 Dividend Stocks to Help You Through the Markets Mayhem InvestorPlace
02:25PM  The Funded: Bay Area startups score over $1B in 16 midweek deals American City Business Journals
10:31AM  Medtronic Valiant(TM) Captivia(TM) Demonstrates Durability, Safety, and Efficacy at Five Years in Transection Patients GlobeNewswire
08:31AM  Medtronic Announces Positive Results from the Largest ENB Study to Aid in Lung Cancer Diagnosis, Staging, and Treatment Preparation in a Single Minimally Invasive Procedure GlobeNewswire
Jan-29-19 04:10PM  Medical Products Industry Outlook: Plenty of Upside Left Zacks
Jan-28-19 07:02AM  Medtronic Announces U.S. Commercial Launch of Mazor X Stealth(TM) Edition for Robotic-Assisted Spine Surgery GlobeNewswire
Jan-25-19 04:17PM  Intuitive Surgical Clobbered On Mounting Expenses As J&J, Medtronic Loom Investor's Business Daily
Jan-24-19 05:50PM  Medtronic (MDT) Gains But Lags Market: What You Should Know Zacks
05:33PM  Medtronic to Acquire EPIX Therapeutics, Expanding Its Cardiac Ablation Portfolio GlobeNewswire
02:56PM  Becton, Dickinson Expected to Continue to Reward Shareholders GuruFocus.com
12:09PM  FDA's warning could impact global market for cardiovascular devices Yahoo Finance
Jan-23-19 08:00AM  Today's Research Reports on Trending Tickers: Abbott Laboratories and Medtronic ACCESSWIRE
Jan-22-19 07:45AM  Medtronic stock falls 0.5% after disappointing angioplasty trial data MarketWatch
07:01AM  Patient-Level Survival Analysis Demonstrates No Link Between Paclitaxel Dose and Mortality in Patients Treated with IN.PACT Admiral DCB GlobeNewswire
Jan-20-19 10:11AM  Weekly CFO Buys Highlight GuruFocus.com
Jan-18-19 03:14PM  Medtronic Stock Is Showing Promise on the Daily Chart TheStreet.com
07:43AM  Jim Cramer Advises His Viewers On Brink's, Medtronic And More Benzinga
Jan-17-19 06:48PM  Cramer's lightning round: 'I'm not endorsing' Fiat Chrysler's stock anymore CNBC
09:01AM  Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery GlobeNewswire
Jan-16-19 05:06PM  5 Health Care Stocks in Gurus' Portfolios GuruFocus.com
11:37AM  Medtronic plc (NYSE:MDT) Investors Are Paying Above The Intrinsic Value Simply Wall St.
Jan-15-19 04:19PM  Why An IBD 50 Stock And Its Close Rival Are Nearing Breakouts Investor's Business Daily
03:00PM  BTIG Says Buy The Dip In Medtronic Benzinga
02:08PM  Microbots Products in Focus After Huge Gains by MBOT Stock InvestorPlace
11:07AM  Why An IBD 50 Stock And Its Close Rival Are Nearing Breakouts Investor's Business Daily
10:01AM  Medtronic Launches Mobile App That Communicates Directly with World's First Smartphone-Connected Pacemakers GlobeNewswire
Jan-14-19 09:15AM  Heading Into Earnings Season with 3 Weeks of Gains Zacks
07:28AM  Insider Buys Of The Week: Dish Network, Hartford Financial, Medtronic Benzinga
07:00AM  Top Medtronic Execs Are Buying Up Stock Barrons.com
Jan-13-19 07:17PM  Here's Why Medtronic Stock Rose 12.6% in 2018 Motley Fool
11:14AM  Weekly CEO Buys Highlight GuruFocus.com
Jan-11-19 06:20PM  Top Insider Buys Highlight for the Week of Jan. 11 GuruFocus.com
04:14PM  Why This Group Is 'An Attractive Destination For Investors' In 2019 Investor's Business Daily
Jan-09-19 01:15PM  Medtronic Plc (MDT) Chairman & CEO Omar Ishrak Bought $1 million of Shares GuruFocus.com
11:01AM  Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare GlobeNewswire
07:00AM  Innovation Puts Medtronic in the Lead Morningstar
06:50AM  Today's Research Reports on Trending Tickers: Tandem Diabetes Care and Medtronic ACCESSWIRE
Jan-08-19 12:14PM  Medtronic CEO pushes back on critics who claim the medical device giant has a 'spotty record' CNBC
10:21AM  Medtronic CEO Omar Ishrak on Mazor X acquisition, 2019 ou... CNBC Videos
07:26AM  3 Big Stock Charts for Tuesday: Microsoft, Medtronic and Intercontinental Exchange InvestorPlace
Jan-07-19 06:46PM  Cramer's lightning round: Be 'very careful' with this stockit's in a 'giant short squeeze' CNBC -6.45%
04:37PM  Why PG&E, Maxar Technologies, and Medtronic Slumped Today Motley Fool
11:25AM  Stocks - Dow Makes Upbeat Start to Week as Trade Optimism Triggers Rally Investing.com
07:58AM  Medtronic Falls 3% Investing.com
Jan-04-19 05:32AM  Medtronic Rises 3% Investing.com
Jan-03-19 11:27AM  Celgene deal is a 'bold' move, says former Medtronic CEO CNBC Videos
09:01AM  New Prediction Feature for Hypoglycemia Now Available in Sugar.IQ(TM) Personal Diabetes Assistant App, Developed by Medtronic and IBM Watson Health GlobeNewswire
Jan-02-19 05:22AM  Medtronic Falls 3% Investing.com
Dec-31-18 12:00PM  New Study Raises Concerns About Overuse of Stents Barrons.com
Dec-28-18 05:50PM  Medtronic (MDT) Dips More Than Broader Markets: What You Should Know Zacks
04:09PM  Will A New Approval Help This Medical Stock Approach A Breakout? Investor's Business Daily
09:01AM  Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference GlobeNewswire
Dec-27-18 04:52PM  Medtronic's Growth Across All Lines Aid, Rising Costs Ail Zacks
02:45PM  Robots, DNA And Implantable Devices Why 2019 Isn't Your Dad's Medtech Investor's Business Daily
07:34AM  The Zacks Analyst Blog Highlights: Amazon, Johnson & Johnson, Home Depot, Medtronic and Paychex Zacks
Dec-26-18 05:54PM  Medtronic Rises 3% Investing.com
03:34PM  2019 will be robust year for health care stocks, says Fre... CNBC Videos
10:47AM  Top Stock Reports for Amazon, Johnson & Johnson & Home Depot Zacks
Dec-24-18 07:18AM  Medtronic Falls 3% Investing.com
06:06AM  Is Medtronic plc (NYSE:MDT) Potentially Underrated? Simply Wall St.
Dec-23-18 09:01AM  Better Buy: Intuitive Surgical vs. Medtronic Motley Fool
Dec-21-18 02:18PM  Medtronic Is Testing the 200-Day Average and I Am Not Too Optimistic TheStreet.com
Dec-20-18 09:30AM  Medtronic (MDT) Down 1.8% Since Last Earnings Report: Can It Rebound? Zacks
Dec-19-18 12:16PM  JPMorgan Upgrades Medtronic After String Of Outperformances Benzinga
08:44AM  Medtronic's Mazor Buyout Creates a New Spine Surgery Major Zacks
02:14AM  Medtronic Completes Acquisition of Mazor Robotics GlobeNewswire
Dec-18-18 05:50PM  Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know Zacks
02:01PM  Why Micro Cap Nemaura Medical Crashed 39.5% Today Motley Fool
Dec-17-18 01:33PM  Health-care sector is still a buy despite recent sell-off, says technician CNBC
09:02AM  FDA Approves Smart Programmer for the InterStim System GlobeNewswire
Dec-11-18 05:50PM  Medtronic (MDT) Stock Moves -0.01%: What You Should Know Zacks
Dec-10-18 10:31AM  Medtronic Named One of America's Best Corporate Citizens in 2018 by Forbes Magazine GlobeNewswire
09:01AM  Insulet Gains on Omnipod Reimbursement Update, Rivalry Stiff Zacks
Dec-08-18 02:30PM  Hedge Funds Are Betting On Medtronic, Inc. (MDT) Insider Monkey
Dec-07-18 11:30AM  Medtronic Canada Recognized as One of Greater Toronto's Top Employers for 2019 CNW Group
08:10AM  Detailed Research: Economic Perspectives on ResMed, Proofpoint, Southwestern Energy, Knowles, Chipotle Mexican Grill, and Medtronic What Drives Growth in Today's Competitive Landscape GlobeNewswire
06:46AM  Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2019 GlobeNewswire
06:33AM  Undervalued Medtronic Looks Like a Healthy Buy Morningstar
Dec-06-18 10:20AM  What Happens to My Stock When a Company in My Portfolio Is Acquired? Motley Fool
Dec-05-18 12:43PM  Jeffrey Talpins Top Stock Picks Insider Monkey
10:08AM  How to Put the Right Priorities Into Your Finances Motley Fool
Dec-04-18 06:53PM  Medtronic to pay $51 mln to resolve U.S. medical device probes Reuters
04:55PM  Medtronic units to pay $31 mln to resolve U.S. medical device probes Reuters
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation product; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; hardware instruments and mesh fixation device; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, colorectal surgeons, urogynecologists, interventional radiologists, and ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and therapy management software. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PARKHILL KAREN LEVP & Chief Financial OfficerJan 09Buy83.873,000251,61083,680Jan 09 12:28 PM
ISHRAK OMARChairman & CEOJan 09Buy84.0512,0001,008,540570,722Jan 09 12:27 PM
Martha GeoffreyEVP & GroupPres Restora TherapSep 24Option Exercise36.5549,7991,820,026109,001Sep 25 04:27 PM
Martha GeoffreyEVP & GroupPres Restora TherapSep 24Sale97.9349,7994,876,66759,202Sep 25 04:27 PM
HAKAMI HOOMANEVP & Group President DiabetesAug 31Option Exercise62.7626,1591,641,73988,806Sep 05 04:33 PM
HAKAMI HOOMANEVP & Group President DiabetesAug 31Sale96.2926,1592,518,79862,647Sep 05 04:33 PM
Kuntz RichardSVP & Chief Medical & ScienceAug 28Option Exercise38.8141,2271,600,020152,579Aug 29 04:38 PM
Kuntz RichardSVP & Chief Medical & ScienceAug 28Sale95.8847,1764,523,089105,403Aug 29 04:38 PM
POZEN ROBERT CDirectorAug 23Option Exercise35.694,484160,03164,182Aug 24 04:32 PM
ANDERSON RICHARD HDirectorAug 23Buy95.882,600249,28576,920Aug 23 05:03 PM
POZEN ROBERT CDirectorAug 23Sale95.943,218308,73860,964Aug 24 04:32 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascAug 22Option Exercise37.01178,2196,596,044345,724Aug 23 04:36 PM
COYLE MICHAEL JEVP & Group Pres, Cardiac&VascAug 22Sale95.50145,54413,899,161200,180Aug 23 04:36 PM
Lerman Bradley ESVP General Counsel & Corp SecJun 11Sale86.828,910773,56651,842Jun 12 04:35 PM
Kuntz RichardSVP & Chief Medical & ScienceJun 08Sale87.1311,5001,001,995105,923Jun 11 04:36 PM
OLEARY DENISE MDirectorApr 17Option Exercise50.341,59080,04157,698Apr 18 06:49 PM
Lenehan James TDirectorMar 13Option Exercise50.341,59080,04148,334Mar 14 05:27 PM
Lenehan James TDirectorMar 13Sale83.561,306109,12347,028Mar 14 05:27 PM
Surface Carol ASVP, Chief HR OfficerMar 05Option Exercise60.1648,6202,925,07778,151Mar 06 04:09 PM
Surface Carol ASVP, Chief HR OfficerMar 05Sale78.3612,479977,85429,531Mar 06 04:09 PM
Surface Carol ASVP, Chief HR OfficerMar 02Sale78.0012,000936,00042,010Mar 06 04:09 PM
ACT AdvisorShares Vice ETF daily Stock Chart
ACT [NASD]
AdvisorShares Vice ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week3.60%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month9.84%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-1.95%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.59 Perf Half Y-4.23%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-4.06%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range20.88 - 27.73 Perf YTD14.73%
Dividend0.39 P/FCF- EPS past 5Y- ROI- 52W High-11.46% Beta-
Dividend %1.59% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low17.59% ATR0.27
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)75.44 Volatility0.89% 1.07%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume2.44 Prev Close24.37
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume4.99K Price24.55
Recom- SMA205.56% SMA508.14% SMA200-1.87% Volume11,944 Change0.73%
Feb-06-19 11:10AM  AdvisorShares Files for Marijuana ETF Zacks
11:07AM  Marijuana ETF Tops $1 Billion in AUM ETF Trends
Jan-30-19 05:32PM  AdvisorShares Eyes Marijuana ETF Listing Benzinga
Jan-29-19 04:40PM  Marijuana ETFs to Access Growing Cannabis Outlook ETF Trends
03:40PM  Marijuana ETF YOLO is in the Works ETF Trends
Dec-27-18 01:00PM  AdvisorShares Announces December 2018 Distributions PR Newswire
Nov-28-18 10:50AM  Another Cannabis ETF on the Way Zacks
Nov-26-18 12:16PM  3 Stocks That Are Absurdly Cheap Right Now Motley Fool
Nov-06-18 08:00AM  Will Cannabis ETFs be on a High Again? Zacks
Oct-15-18 08:02AM  This Sin-Stock ETF's Marijuana Moves Have Missed the Mark Motley Fool
Oct-11-18 01:45PM  Fans of Tilray Stock Ought to Ride MJ to Success InvestorPlace
Sep-17-18 08:52AM  The Zacks Analyst Blog Highlights: United States Gasoline, Invesco Dynamic Building & Construction, Materials Select Sector SPDR Fund and AdvisorShares VICE Zacks
Sep-14-18 01:25PM  4 ETFs Set to Soar in the Aftermath of Hurricane Florence Zacks
Sep-12-18 12:00PM  Why Bausch Health Companies Inc. Stock Is Booming Today Motley Fool
Aug-21-18 10:18AM  5 Vice ETFs That Are Worth Sinning For InvestorPlace
Aug-17-18 07:31AM  If I Had to Buy 1 Stock in August, It Would Be This One Motley Fool
Aug-02-18 07:42PM  Allergan sues Pfizer over costs of opioid litigation Reuters
04:48PM  Allergan sues Pfizer over costs of opioid litigation Reuters
04:16PM  Allergan sues Pfizer over costs of opioid litigation Reuters
02:31PM  Allergan Sues Pfizer Over Damages in Opioid Litigation Bloomberg
11:55AM  Marijuana ETFs: The Pros and Cons Investopedia
Jul-26-18 10:02AM  3 Charts Suggest It's Time to Invest in Sin Stocks Investopedia
Jul-02-18 11:26PM  Here Are the Only Two Marijuana ETFs U.S. Investors Need Consider InvestorPlace
Jun-21-18 10:55AM  Canada Legalizes Marijuana: Two ETFs to Tap the Boom Zacks
Jun-20-18 02:12PM  Marijuana ETFs Grow on Canadian Parliaments Ruling ETF Trends
May-21-18 03:44PM  Marijuana Stocks: This Unique Weed Merger Offers Tech, Eyes U.S. Listing Investor's Business Daily
May-17-18 12:40PM  Marijuana ETFs Experience Setbacks Investopedia
May-07-18 03:26PM  3 Marijuana ETFs for Everyday Investors to Play the Cannabis Movement InvestorPlace
Apr-20-18 10:54AM  4/20: Marijuana, hemp legalization moves ahead in many states Yahoo Finance Video
09:07AM  Futures point slightly lower, Trump bashes OPEC over oil prices Yahoo Finance
Feb-16-18 03:31PM  United Therapeutics reaches patent settlement with Actavis American City Business Journals
03:16PM  United Therapeutics settles patent litigation over $157M drug American City Business Journals
Feb-14-18 09:58AM  Marijuana and Blockchain: 2018's Hottest New ETFs Zacks
Feb-06-18 12:20PM  Allergan CEO: We Are Staying in Ireland TheStreet.com
Feb-01-18 08:49AM  Allergan to pay Israel's Teva Pharm $700 million to settle dispute Reuters
Jan-17-18 12:14AM  [$$] Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant The Wall Street Journal
Jan-16-18 06:02PM  [$$] Judge Signals He Will Approve Settlement Between Allergan Shareholders and Pershing, Valeant The Wall Street Journal
Jan-11-18 04:25PM  What Investors Need to Know About Marijuana ETFs Zacks
03:33PM  Ackmans Pershing Square cuts hedge-fund fees due to lawsuit settlement MarketWatch
Jan-10-18 09:52AM  'New' Fund Soars To Record High: Is Cannabis The New Bitcoin? Investor's Business Daily
Jan-04-18 04:12PM  Pot Stock Plays Fall, But Here's Why Jeff Sessions May Not Matter Much Investor's Business Daily
Dec-30-17 10:16AM  Bill Ackman And Valeant Settle Allergan Insider Trading Lawsuit For $290 Million Forbes
Dec-29-17 11:31PM  [$$] Pershing Square, Valeant to Pay $290 Million to Settle Allergan Suit The Wall Street Journal
02:16PM  Pershing Square, Valeant arrive at settlement split for Allergan lawsuit Reuters
01:28PM  Pershing Square, Valeant to Pay $290 Million to End Lawsuit Bloomberg
01:07PM  Valeant says parties in Allergan litigation have agreed to resolve claims of $290 million MarketWatch
Dec-28-17 02:27PM  Rush for Marijuana ETFs Getting Stronger Zacks
Dec-26-17 12:44AM  [$$] Judge Sides Against Ackman and Valeant in Preliminary Allergan Ruling The Wall Street Journal
Dec-20-17 08:00AM  This Week's ETF Launches: Introducing the First Quadruple-Leveraged Products ETF Database
Dec-13-17 02:58PM  Sin Is In With New Vice ETF ETF Trends
The investment seeks long-term capital appreciation. The fund is an actively-managed exchange-traded fund that invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from tobacco and alcoholic beverages and companies that derive at least 50% of their net revenue from the marijuana and hemp industry or have at least 50% of their company assets dedicated to lawful research and development of cannabis or cannabinoid-related products. It will invest primarily in U.S. exchange listed equity securities, including common and preferred stock and ADRs.
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-15.33 Insider Own0.10% Shs Outstand336.32M Perf Week5.28%
Market Cap46.77B Forward P/E7.96 EPS next Y17.47 Insider Trans3.68% Shs Float336.28M Perf Month-9.04%
Income-5142.80M PEG- EPS next Q3.55 Inst Own90.80% Short Float1.36% Perf Quarter-14.50%
Sales15.79B P/S2.96 EPS this Y-543.10% Inst Trans2.78% Short Ratio1.51 Perf Half Y-24.62%
Book/sh207.99 P/B0.67 EPS next Y6.82% ROA-1.60% Target Price190.41 Perf Year-16.54%
Cash/sh3.60 P/C38.66 EPS next 5Y5.21% ROE-2.50% 52W Range125.84 - 197.00 Perf YTD4.05%
Dividend2.96 P/FCF10.26 EPS past 5Y4.77% ROI-2.10% 52W High-29.41% Beta1.35
Dividend %2.13% Quick Ratio0.80 Sales past 5Y21.90% Gross Margin86.10% 52W Low10.51% ATR3.95
Employees17800 Current Ratio0.90 Sales Q/Q-3.00% Oper. Margin-19.50% RSI (14)42.76 Volatility2.12% 2.76%
OptionableYes Debt/Eq0.33 EPS Q/Q99.10% Profit Margin-11.30% Rel Volume0.99 Prev Close138.67
ShortableYes LT Debt/Eq0.32 EarningsJan 29 BMO Payout- Avg Volume3.02M Price139.07
Recom2.10 SMA20-4.74% SMA50-4.12% SMA200-16.44% Volume2,996,156 Change0.29%
Jan-31-19Downgrade Credit Suisse Outperform → Neutral
Jan-30-19Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-30-19Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-19-17Reiterated RBC Capital Mkts Outperform $277 → $250
Oct-17-17Reiterated UBS Buy $275 → $255
Oct-02-17Reiterated Barclays Equal Weight
Sep-25-17Reiterated RBC Capital Mkts Outperform $285 → $277
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
Feb-18-19 10:50PM  ALLERGAN 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Allergan plc. - AGN Business Wire
04:39PM  FINAL DEADLINE ALERT - February 19, 2019 - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) and Lead Plaintiff Deadline ACCESSWIRE
12:38PM  FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) and Lead Plaintiff Deadline - February 19, 2019 ACCESSWIRE
12:00PM  DEADLINE TOMORROW for GS, XRAY, NVDA and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:34AM  Dentsply Sirona, Inc. (XRAY), The Goldman Sachs Group, Inc. (GS), Allergan plc (AGN) & JA Solar Holdings Co. Ltd. (JASO): Bronstein, Gewirtz & Grossman, LLC Announces Final Deadline ACCESSWIRE
08:00AM  CLASS ACTION UPDATE for XRAY, DBVT, AGN and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-17-19 05:00PM  CLASS ACTION UPDATE for DNKEY, YOGA, AGN and MHLD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:00AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of XRAY, AGN, ALKS and SVXY GlobeNewswire
07:12AM  CLASS ACTION UPDATE for XRAY, NVDA, AGN and YRIV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-15-19 10:50PM  ALLERGAN 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against Allergan plc. - AGN Business Wire
05:48PM  Allergan PLC (AGN) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
01:15PM  CLASS ACTION UPDATE for ARLO, AGN and UXIN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:55PM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline - February 19, 2019 ACCESSWIRE
12:29PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline - February 19, 2019 ACCESSWIRE
10:15AM  CLASS ACTION UPDATE for AGN, ATVI, TYME and GE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:55AM  Dentsply Sirona, Inc. (XRAY), The Goldman Sachs Group, Inc. (GS) & Allergan plc (AGN): Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
07:30AM  Allergan to Present at The 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-14-19 03:50PM  CLASS ACTION UPDATE for ARLO, SOGO, NVDA and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:33PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
03:01PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline - February 19, 2019 ACCESSWIRE
02:04PM  CLASS ACTION UPDATE for ARLO, AGN, ALKS and MKL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
01:00PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline - February 19, 2019 ACCESSWIRE
12:03PM  FDA Panel Nod for J&J's Esketamine Is Good News for Allergan, Vistagen GuruFocus.com
10:02AM  Ironwood (IRWD) Q4 Earnings & Revenues Beat, Shares Rise Zacks
08:41AM  Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down Zacks
07:00AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of GS, XRAY, NVDA and AGN GlobeNewswire
Feb-13-19 08:00PM  CLASS ACTION UPDATE for SOGO, PRGO, AGN and ALKS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
05:17PM  Why Ironwood's Shares Climbed 11.7% on Wednesday Motley Fool
03:57PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SOGO, PRGO, AGN and ALKS GlobeNewswire
01:29PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline - February 19, 2019 ACCESSWIRE
10:28AM  J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod Zacks
10:19AM  CLASS ACTION UPDATE for YOGA, YRCW, IMMU and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-12-19 10:50PM  ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan plc. - AGN GlobeNewswire
07:00PM  CLASS ACTION UPDATE for GS, XRAY, NVDA and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:30PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline AGN ACCESSWIRE
02:47PM  CLASS ACTION UPDATE for ARLO, SOGO, IMMU and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
02:00PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of SOGO, IMMU, AGN and W GlobeNewswire
11:00AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dentsply Sirona, Inc. (XRAY), The Goldman Sachs Group, Inc. (GS) Allergan plc (AGN) & JA Solar Holdings Co. Ltd. (JASO) GlobeNewswire
10:36AM  CLASS ACTION UPDATE for XRAY, AGN, MU and ASTE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-11-19 04:59PM  CLASS ACTION UPDATE for PRGO, NVDA, AGN and ASTE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:00PM  FDA Panel Reviews Johnson & Johnson's Treatment-Resistant Depression Candidate: What To Expect Benzinga
02:03PM  CLASS ACTION UPDATE for XRAY, AGN and WRCDF/WCAGY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:03AM  CLASS ACTION UPDATE for IMMU, AGN, MAXR and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-10-19 10:09AM  CLASS ACTION UPDATE for GS, XRAY, NVDA and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-09-19 01:26AM  Stocks That Fell to 3-Year Lows in the Week of Feb. 8 GuruFocus.com
Feb-08-19 10:50PM  ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan plc.  AGN GlobeNewswire
02:58PM  CLASS ACTION UPDATE for IMMU, AGN, MAXR and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:47PM  CLASS ACTION UPDATE for DNKEY, GS, AGN and MKL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:17PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline - February 19, 2019 ACCESSWIRE
10:33AM  CLASS ACTION UPDATE for PRGO, AXGN, AGN and TYME: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-07-19 07:08PM  Aesthetics company behind latest Botox rival was 'designed' to compete with Botox: CEO CNBC Videos
05:48PM  Allergan Tumbles Despite Pressure From David Tepper GuruFocus.com
04:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
04:54PM  Block & Leviton LLP Reminds Shareholders of Important Deadlines; TS, TDOC, XPO, AGN GlobeNewswire
03:28PM  CLASS ACTION UPDATE for ARLO, XRAY, PRGO and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:12PM  5 Undervalued Stocks to Invest In InvestorPlace
12:21PM  CLASS ACTION UPDATE for ARLO, AXGN, AGN and SVXY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:05AM  CLASS ACTION UPDATE for ARLO, XRAY, AXGN and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-06-19 02:15PM  CLASS ACTION UPDATE for GS, ARLO, XRAY and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:11AM  CLASS ACTION UPDATE for SOGO, AGN, MAXR and ATVI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:00AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dentsply Sirona, Inc. (XRAY), The Goldman Sachs Group, Inc. (GS) and Allergan plc (AGN) GlobeNewswire
09:56AM  XPO, AGN, IMMU: Block & Leviton LLP Reminds Shareholders of Important Deadlines GlobeNewswire
07:03AM  CLASS ACTION UPDATE for GS, XPO, NVDA and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-05-19 05:31PM  CLASS ACTION UPDATE for AGN, YRIV and MKL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
04:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc. of Class Action Lawsuit and Upcoming Deadline AGN ACCESSWIRE
04:36PM  Activist Investor Urges Allergan To Divide CEO-Chairman Role Investor's Business Daily
04:19PM  Botox Maker Allergan Falls After Tepper's Hedge Fund Challenges Management TheStreet.com
03:02PM  3 Biotech Stocks That Pay Solid Dividends InvestorPlace
01:46PM  Appaloosa's David Tepper submits new proposal to shareholders CNBC Videos
12:55PM  CLASS ACTION UPDATE for GS, XPO, XRAY and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:41PM  Appaloosa steps up pressure on Allergan to split chairman, CEO roles Reuters
12:00PM  3 Red-Hot Stocks (And 3 That Arent) InvestorPlace
11:55AM  Stocks making the biggest moves midday: Estee Lauder, Ralph Lauren, Alphabet & more CNBC
11:47AM  Appaloosa again pushes for Allergan to make management changes MarketWatch
09:55AM  Allergan stock rises after David Tepper's Appaloosa ups pressure on the struggling drugmaker CNBC
09:40AM  Hedge fund Appaloosa urges Allergan to separate the roles of chairman and CEO positions CNBC Videos
09:31AM  Hedge fund Appaloosa urges Allergan to separate roles of chairman, CEO again Reuters
08:15AM  Allergan Stock Falls as FDA OK's Botox Rival for Frown Lines Zacks
07:23AM  CLASS ACTION UPDATE for XRAY, IMMU, AGN and DXC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-04-19 11:02PM  [$$] Appaloosa steps up call for Botox maker Allergan to split leadership roles Financial Times
04:41PM  Papa John's, Evolus rise; Gannett, Allergan slip Associated Press
04:38PM  US STOCKS-Boost in tech shares sends Wall Street higher Reuters
04:20PM  Allergan Slides, Evolus Gains as FDA Approves Wrinkle Treatment to Rival Botox TheStreet.com
04:15PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YOGA, XRAY, AGN and SVXY GlobeNewswire
03:00PM  US STOCKS-Tech boost sends Wall Street higher Reuters
02:16PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan plc (AGN) & Lead Plaintiff Deadline: February 19, 2019 ACCESSWIRE
01:37PM  US STOCKS-Tech boost pushes Wall Street to session highs Reuters
12:30PM  SHAREHOLDER ALERT: WBT XPO XRAY AGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
11:39AM  US STOCKS-Tech boosts S&P, Nasdaq; healthcare weighs on Dow Reuters
06:36AM  UPDATE 1-FDA approves cheaper Botox rival to treat frown lines (Feb.1) Reuters
06:33AM  Evolus Rises Midday as Botox Drama Unfolds Investing.com
Feb-03-19 10:07AM  CLASS ACTION UPDATE for GS, XRAY, AGN and DXC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Feb-01-19 10:50PM  ALLERGAN SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Allergan plc. - AGN Business Wire
07:32PM  FDA approves cheaper Botox rival to treat frown lines Reuters
06:40PM  FDA approves cheaper Botox rival to treat frown lines Reuters
05:48PM  FDA approves cheaper Botox rival to treat frown lines Reuters
05:06PM  FDA approves cheaper Botox rival to treat frown lines Reuters
04:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of XRAY, IMMU, AGN and DXC GlobeNewswire
12:20PM  Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of GS, XRAY, NVDA and AGN GlobeNewswire
11:14AM  Allergan plc (NYSE:AGN): Financial Strength Analysis Simply Wall St.
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology, and anti-infective therapeutic categories. It also provides breast implants and tissue expanders; RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis; ocular implants; and Kybella, a non-surgical treatment for submental fullness. In addition, the company develops therapies for non-alcoholic steatohepatitis and other liver diseases; treatments for neurodegenerative disorders, including Alzheimer's disease; small molecule therapeutics that target inflammatory and fibrotic diseases; and delivery system and botulinum toxin-based prescription products. It has collaboration, option, and license agreement with Lyndra, Inc.; strategic alliance and option agreement with Editas Medicine, Inc.; and licensing agreements with Assembly Biosciences, Inc. MedImmune, and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALSH MATTHEW MEVP, Chief Financial OfficerNov 16Buy157.001,000157,00026,416Nov 19 07:22 PM
COUGHLIN CHRISTOPHER JDirectorSep 06Buy190.6410,0001,906,39416,431Sep 07 08:31 AM
Boccuzi Joseph HDirectorAug 30Buy190.59900171,5313,885Sep 04 05:06 PM
FREYMAN THOMAS CDirectorAug 30Buy190.691,100209,7592,658Sep 04 05:07 PM
Basgoz NesliDirectorAug 30Sale190.051,055200,5037,359Sep 04 05:08 PM
Basgoz NesliDirectorAug 10Option Exercise81.161,889153,3119,248Aug 14 05:32 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Option Exercise68.1121,2521,447,47440,154May 21 05:21 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Sale154.5924,4253,775,86115,729May 21 05:21 PM
Hilado Maria TeresaExecutive Vice PresidentMar 15Buy167.39895149,81426,530Mar 19 09:36 AM
WALSH MATTHEW MEVP, Chief Financial OfficerMar 08Buy153.961,000153,96025,416Mar 08 10:44 AM
SAUNDERS BRENT LChairman, President and CEOMar 08Buy152.533,300503,349180,931Mar 08 10:25 AM
Boccuzi Joseph HDirectorMar 05Buy143.42900129,0781,862Mar 09 04:31 PM
WALSH MATTHEW MEVP, Chief Financial OfficerFeb 21Buy160.942,000321,88024,416Feb 22 04:25 PM
COST Costco Wholesale Corporation daily Stock Chart
COST [NASD]
Costco Wholesale Corporation
IndexS&P 500 P/E29.18 EPS (ttm)7.42 Insider Own0.40% Shs Outstand439.16M Perf Week4.20%
Market Cap95.06B Forward P/E25.86 EPS next Y8.37 Insider Trans-3.66% Shs Float438.16M Perf Month2.99%
Income3.28B PEG2.75 EPS next Q1.69 Inst Own74.00% Short Float1.15% Perf Quarter-7.55%
Sales144.84B P/S0.66 EPS this Y17.50% Inst Trans1.64% Short Ratio1.96 Perf Half Y-2.35%
Book/sh29.98 P/B7.22 EPS next Y8.94% ROA8.00% Target Price236.83 Perf Year15.54%
Cash/sh18.11 P/C11.95 EPS next 5Y10.60% ROE26.20% 52W Range180.83 - 245.16 Perf YTD6.26%
Dividend2.28 P/FCF50.67 EPS past 5Y9.00% ROI16.40% 52W High-11.70% Beta0.94
Dividend %1.05% Quick Ratio0.50 Sales past 5Y6.10% Gross Margin12.90% 52W Low19.71% ATR3.35
Employees143000 Current Ratio1.00 Sales Q/Q10.20% Oper. Margin3.10% RSI (14)63.42 Volatility1.37% 1.57%
OptionableYes Debt/Eq0.00 EPS Q/Q19.30% Profit Margin2.30% Rel Volume1.02 Prev Close213.84
ShortableYes LT Debt/Eq0.49 EarningsMar 07 AMC Payout28.80% Avg Volume2.57M Price216.47
Recom2.20 SMA202.48% SMA502.75% SMA200-0.29% Volume2,635,500 Change1.23%
Dec-24-18Reiterated Argus Buy $255 → $245
Dec-03-18Downgrade Citigroup Buy → Neutral
Oct-12-18Upgrade Northcoast Neutral → Buy
Sep-14-18Downgrade Wells Fargo Outperform → Market Perform
Sep-05-18Reiterated Telsey Advisory Group Outperform $230 → $250
Aug-21-18Reiterated Argus Buy $220 → $255
Aug-07-18Reiterated Telsey Advisory Group Outperform $220 → $230
Jul-25-18Downgrade Gordon Haskett Buy → Accumulate
Jul-06-18Downgrade Northcoast Buy → Neutral
Jun-01-18Reiterated Telsey Advisory Group Outperform $210 → $220
May-17-18Initiated Loop Capital Buy $224
Apr-16-18Upgrade Wells Fargo Market Perform → Outperform
Mar-08-18Reiterated RBC Capital Mkts Outperform $209 → $205
Jan-12-18Upgrade Gordon Haskett Accumulate → Buy
Jan-12-18Reiterated Telsey Advisory Group Outperform $195 → $195
Dec-15-17Reiterated Telsey Advisory Group Outperform $186 → $195
Dec-04-17Initiated MoffettNathanson Buy
Nov-30-17Reiterated Stifel Buy $179 → $185
Oct-06-17Downgrade Morgan Stanley Overweight → Equal-Weight $165
Jun-26-17Upgrade Raymond James Mkt Perform → Outperform
Feb-18-19